azathioprine has been researched along with Cadaver in 426 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Cadaver: A dead body, usually a human body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF." | 9.10 | Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. ( Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M, 2003) |
| " Recipients of first cadaveric kidney allografts were treated with tacrolimus+mycophenolate mofetil (MMF), cyclosporine oral solution (modified) (CsA)+MMF, or tacrolimus+azathioprine (AZA)." | 9.09 | Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. ( Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M, 2001) |
| "We performed a prospective randomized trial to compare the efficacy and safety of tacrolimus (FK506) versus cyclosporine (CSA) in black primary cadaveric renal transplant (CRT) recipients." | 9.09 | A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants. ( Bartholomew, AM; Benedetti, E; Coady, N; Dunn, TB; Holman, DM; Pollak, R; Raofi, V; Vazquez, E, 1999) |
| "In this randomized controlled trial started in October 1990, 354 cadaveric kidney transplant recipients were assigned to receive either cyclosporine (CsA) monotherapy (115 patients), CsA + steroids (117 patients), or CsA + steroids + azathioprine (122 patients)." | 9.09 | Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. ( Altieri, P; Cambi, V; Carmellini, M; Castagneto, M; Cossu, M; Ferrara, R; Mastrangelo, F; Montagnino, G; Pisani, F; Ponticelli, C; Rizzo, G; Salvadori, M; Segoloni, GP; Tarantino, A, 2001) |
| "Tacrolimus in combination with an initial dose of MMF 2 g/day is a very effective and safe regimen in cadaveric kidney transplant recipients." | 9.09 | Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. ( Jensik, SC; Mendez, R; Miller, J; Pirsch, JD, 2000) |
| "The updated data on 61 consecutive cadaveric transplants performed at our institution from 1987 to 1990 (followup 31 to 82 months, median 54 months) were analyzed with emphasis on cyclosporine monitoring and long-term results." | 9.08 | Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection. ( Baker, SP; Khauli, RB; Lovewell, TD; Stoff, JS; Valliere, SA; Wilson, JM, 1995) |
| "We conducted a randomized trial in seven Australian hospitals of the efficacy and safety of three immunosuppressive regimens after first transplantation of a cadaver kidney: long-term cyclosporine, short-term (three months) cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine." | 9.06 | Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. ( Hall, BM; Hardie, I; Mahony, J; Mathew, T; Miach, P; Sheil, AG; Thatcher, G; Thomson, N; Tiller, DJ, 1988) |
| "We randomized 158 recipients of cadaver renal allografts to cyclosporine-prednisone (83) or antilymphocyte globulin-azathioprine-prednisone (75) to evaluate: the effects of immunosuppression and pretransplant risk factors on the incidence of delayed graft function, the effects of immunosuppression on the resolution of delayed graft function, and the effects of delayed graft function and pretransplanted risk factors on patient and graft survival." | 9.06 | The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. ( Ascher, NL; Canafax, DM; Fryd, DS; Heil, JE; Najarian, JS; Payne, WD; Simmons, RL; Strand, MH; Sutherland, DE; Torres, A, 1986) |
| "In a prospective randomized clinical trial to compare treatment with cyclosporin A to conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in cadaveric renal transplantation, 34 patients were entered into both treatment groups and were examined regularly for seven to 43 months." | 9.05 | Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation. ( Duggin, GG; Hall, BM; Harris, JP; Horvath, JS; Hurley, B; Johnson, JR; Rogers, JR; Roy, LP; Stephen, MS; Tiller, DJ, 1985) |
| "In order to evaluate whether immunosuppressive agents such as mycophenolate mofetil (MMF) and azathioprine would differently influence the outcome of the renal transplants, we prospectively analyzed the incidence of acute rejection episodes, cytomegalovirus infection within the first 6 months following renal transplantation and 5 yr graft survival rate after minimizing influences of donor factors by grafting the same cadaveric donor kidney." | 7.73 | The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation. ( Joh, JW; Kim, SJ; Lee, DS; Lee, HH; Lee, KW; Lee, SK, 2005) |
| "A recent report noted that cyclosporine (CsA) inhibits replication of the hepatitis C virus (HCV) in vitro." | 7.73 | Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus. ( Arichi, N; Fujii, N; Ichikawa, Y; Kishikawa, H; Kyo, M; Nishikawa, M; Nishimura, K; Tokugawa, S; Yoshioka, I, 2006) |
| "A previous study has argued that mycophenolate mofetil (MMF) is associated with a reduced incidence of death with function when compared to azathioprine (AZA) in cadaveric renal transplantation." | 7.72 | Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. ( Brennan, DC; Craig, KE; Hardinger, KE; Lowell, JA; Schnitzler, MA, 2003) |
| "We analyzed 128 cadaveric first renal transplant recipients with CsA and prednisone as basal immunosuppression followed for at least 10 years, and we have compared them with a group of 185 historical patients treated with azathioprine (Aza) and prednisone." | 7.71 | Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss? ( Burgos, FJ; Mampaso, F; Marcén, R; Ortuño, J; Pascual, J; Rivera, ME; Teruel, JL; Villafruela, JJ, 2001) |
| "Recent multicenter reports have demonstrated improved outcome in recipients of cadaveric renal transplants treated with mycophenolate mofetil (MMF) versus azathioprine (AZA) in combination with cyclosporine A (CSA) and prednisone." | 7.70 | Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. ( Alfrey, EJ; Dafoe, DC; Lee, CM; Markezich, AJ; Scandling, JD, 1998) |
| "Infectious complications within 1 year of cadaveric kidney transplantation were compared in 45 patients treated with azathioprine, prednisone, and antilymphocyte globulin and 38 patients treated with cyclosporine and prednisone." | 7.67 | Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation. ( Hammer, SM; Monaco, AP; Shaffer, D, 1987) |
| "Tacrolimus-treated patients had a lower incidence of hyperlipidemia through 6 months posttransplant." | 6.69 | Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. ( Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield, C; Sorensen, J; Stegall, M; Tolzman, D; van Veldhuisen, P; Wachs, M, 2000) |
| "Azathioprine was instituted in a total of 51 patients randomized to double therapy." | 6.67 | A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. ( Albrechtsen, D; Groth, CG; Karlberg, I; Lindholm, A; Persson, NH; Tufveson, G, 1992) |
| "With its incidence of about 40%, acute renal failure (ARF) is a major problem after cadaveric renal transplantation." | 6.66 | Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. ( Berden, JH; Hoitsma, AJ; Koene, RA; Tiggeler, RG; van Lier, HJ; van Valenberg, PL, 1987) |
| "The azathioprine treated group (AZA group) included 280 patients (132 female) treated for 17,672 months with AZA + Cyclosporine A (CyA) + steroid, or AZA + steroid, while the MMF group included 219 patients (112 female) treated for 5079 months with MMF + CyA + steroid, or MMF + steroid." | 5.33 | Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation? ( Basic-Jukic, N; Brunetta, B; Bubic-Filipi, LJ; Kes, P; Pasini, J; Puretic, Z, 2005) |
| "Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF." | 5.10 | Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. ( Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M, 2003) |
| "This report extends the randomized, double-blind, multicenter trial at 14 centers in the United States that compared triple-therapy regimens containing mycophenolate mofetil (MMF), 2 or 3 g, with a similar regimen containing azathioprine (AZA) in recipients of cadaveric renal allografts." | 5.09 | Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group. ( , 1999) |
| "Tacrolimus in combination with an initial dose of MMF 2 g/day is a very effective and safe regimen in cadaveric kidney transplant recipients." | 5.09 | Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. ( Jensik, SC; Mendez, R; Miller, J; Pirsch, JD, 2000) |
| " Recipients of first cadaveric kidney allografts were treated with tacrolimus+mycophenolate mofetil (MMF), cyclosporine oral solution (modified) (CsA)+MMF, or tacrolimus+azathioprine (AZA)." | 5.09 | Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. ( Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M, 2001) |
| "We performed a prospective randomized trial to compare the efficacy and safety of tacrolimus (FK506) versus cyclosporine (CSA) in black primary cadaveric renal transplant (CRT) recipients." | 5.09 | A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants. ( Bartholomew, AM; Benedetti, E; Coady, N; Dunn, TB; Holman, DM; Pollak, R; Raofi, V; Vazquez, E, 1999) |
| "In this randomized controlled trial started in October 1990, 354 cadaveric kidney transplant recipients were assigned to receive either cyclosporine (CsA) monotherapy (115 patients), CsA + steroids (117 patients), or CsA + steroids + azathioprine (122 patients)." | 5.09 | Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. ( Altieri, P; Cambi, V; Carmellini, M; Castagneto, M; Cossu, M; Ferrara, R; Mastrangelo, F; Montagnino, G; Pisani, F; Ponticelli, C; Rizzo, G; Salvadori, M; Segoloni, GP; Tarantino, A, 2001) |
| "The updated data on 61 consecutive cadaveric transplants performed at our institution from 1987 to 1990 (followup 31 to 82 months, median 54 months) were analyzed with emphasis on cyclosporine monitoring and long-term results." | 5.08 | Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection. ( Baker, SP; Khauli, RB; Lovewell, TD; Stoff, JS; Valliere, SA; Wilson, JM, 1995) |
| " We conducted a prospective, double-blind, multi-center trial to compare the efficacy and safety of MMF and azathioprine within standard immunosuppressive regimen for patients receiving a first or second cadaveric renal graft." | 5.08 | A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. ( , 1996) |
| "A controlled trial was carried out in 209 primary cadaveric renal transplants to compare the effects of cyclosporine and steroids (double therapy) with those of cyclosporine in lower initial dose, azathioprine, and steroids (triple therapy)." | 5.06 | A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. ( Brinker, KR; Dickerman, RM; Gonwa, TA; Hull, AR; Langley, JW; Long, DL; Nesser, DA; Trevino, G; Velez, RL; Vergne-Marini, PJ, 1990) |
| "We randomized 158 recipients of cadaver renal allografts to cyclosporine-prednisone (83) or antilymphocyte globulin-azathioprine-prednisone (75) to evaluate: the effects of immunosuppression and pretransplant risk factors on the incidence of delayed graft function, the effects of immunosuppression on the resolution of delayed graft function, and the effects of delayed graft function and pretransplanted risk factors on patient and graft survival." | 5.06 | The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. ( Ascher, NL; Canafax, DM; Fryd, DS; Heil, JE; Najarian, JS; Payne, WD; Simmons, RL; Strand, MH; Sutherland, DE; Torres, A, 1986) |
| "In a multicentre trial conducted in eight European centres, 232 recipients of cadaveric renal allografts were randomly allocated to receive either cyclosporin A (CyA, 117 patients) or azathioprine and steroids (control, 115 patients) for immunosuppression." | 5.05 | Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial. ( , 1982) |
| "In a multicentre trial conducted in eight European centres, 232 recipients of cadaveric renal allografts were randomly allocated to receive either cyclosporin (117 patients) or azathioprine and steroids (115 patients) for immunosuppression." | 5.05 | Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial. ( , 1983) |
| "Herein are presented the results of a controlled prospective randomized double-blind evaluation of antilymphoblast globulin as an immunosuppressive adjunct to azathioprine and prednisone in cadaver renal transplantation." | 5.05 | A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation. ( Braun, WE; Buszta, C; Greenstreet, R; Kiser, W; Novick, AC; Steinmuller, D, 1983) |
| " From March 1979 to November 1981 a randomised controlled trial of high (33 patients) v low oral dose (34 patients) of prednisolone along with azathioprine was conducted in recipients of first cadaveric transplants who had received a blood transfusion within six months of transplantation." | 5.05 | High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. ( Adu, D; Bewick, M; Brown, CB; Cameron, JS; Donaghey, R; Ogg, CS; Papadakis, J; Rudge, C; Taube, D; Williams, DG, 1983) |
| "In a prospective randomized clinical trial to compare treatment with cyclosporin A to conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in cadaveric renal transplantation, 34 patients were entered into both treatment groups and were examined regularly for seven to 43 months." | 5.05 | Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation. ( Duggin, GG; Hall, BM; Harris, JP; Horvath, JS; Hurley, B; Johnson, JR; Rogers, JR; Roy, LP; Stephen, MS; Tiller, DJ, 1985) |
| " To avoid this potential interaction we treated recipients of primary cadaveric grafts initially with azathioprine (AZA), methylprednisolone (MP), and 5 daily doses of Minnesota antilymphoblast globulin (MAG) (postoperative days 3-7)." | 5.05 | Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation. ( Dienst, S; Kupin, WL; Levin, NW; Oh, HK; Venkatachalam, KK, 1985) |
| "The outcome of patients with acute renal failure following cadaveric renal transplant has been evaluated in a prospective, controlled trial, comparing treatment with cyclosporine (CSA) to prednisone, azathioprine, and antilymphocyte globulin (AZA)." | 5.05 | Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine. ( Duggin, GG; Farnsworth, A; Hall, BM; Horvath, JS; Johnson, JR; May, J; Sheil, AG; Tiller, DJ, 1985) |
| " There was no difference between the 17 recipients of related donor organs who received alternate-day prednisone (experimentals) and their 15 controls who received daily prednisone nor between the 11 experimental and 10 control recipients of cadaver donor organs as regards: rejections per patient month, change in serum creatinine, doses of azathioprine or prednisone, or weight." | 5.04 | Effect of alternate-day steroids on renal transplant function. A controlled study. ( Horensten, ML; Mayor, GB; McDonald, FD; Schork, MA; Selezinka, W; Turcotte, JG, 1976) |
| " Cadaver renal allograft recipients were randomized into two treatment groups: prednisone and azathioprine only, or prednisone, azathioprine, and ATG." | 5.04 | Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. ( Cosimi, AB; Delmonico, FL; Russell, PS; Wortis, HH, 1976) |
| "Ninety-four patients receiving immunosuppressive therapy with azathioprine and prednisone after human cadaver kidney transplantation developed urinary tract infections and were treated with co-trimoxazole or another antibiotic in a controlled randomized prospective trial." | 5.04 | Co-trimoxazole and azathioprine: a safe combination. ( Hall, CL, 1974) |
| "In order to evaluate whether immunosuppressive agents such as mycophenolate mofetil (MMF) and azathioprine would differently influence the outcome of the renal transplants, we prospectively analyzed the incidence of acute rejection episodes, cytomegalovirus infection within the first 6 months following renal transplantation and 5 yr graft survival rate after minimizing influences of donor factors by grafting the same cadaveric donor kidney." | 3.73 | The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation. ( Joh, JW; Kim, SJ; Lee, DS; Lee, HH; Lee, KW; Lee, SK, 2005) |
| " Significant risk factors for post-transplant UTIs were advanced age, female gender, reflux kidney disease, use of azathioprine and cadaveric donor." | 3.73 | Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. ( Chuang, P; Langone, A; Parikh, CR, 2005) |
| "A recent report noted that cyclosporine (CsA) inhibits replication of the hepatitis C virus (HCV) in vitro." | 3.73 | Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus. ( Arichi, N; Fujii, N; Ichikawa, Y; Kishikawa, H; Kyo, M; Nishikawa, M; Nishimura, K; Tokugawa, S; Yoshioka, I, 2006) |
| "A previous study has argued that mycophenolate mofetil (MMF) is associated with a reduced incidence of death with function when compared to azathioprine (AZA) in cadaveric renal transplantation." | 3.72 | Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. ( Brennan, DC; Craig, KE; Hardinger, KE; Lowell, JA; Schnitzler, MA, 2003) |
| "To compare the effects of four discharge regimens (cyclosporine and azathioprine [CYA+AZA], CYA and mycophenolate mofetil [MMF], tacrolimus [TAC]+AZA, and TAC+MMF) on long-term survival, a multivariate Cox regression analysis was conducted on 19246 primary cadaveric kidney transplants during 1995 to 1998." | 3.72 | A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation. ( Bleyer, AJ; Cherikh, WS; Johnson, CP; Maghirang, J; Myron Kauffman, H, 2003) |
| "We analyzed 128 cadaveric first renal transplant recipients with CsA and prednisone as basal immunosuppression followed for at least 10 years, and we have compared them with a group of 185 historical patients treated with azathioprine (Aza) and prednisone." | 3.71 | Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss? ( Burgos, FJ; Mampaso, F; Marcén, R; Ortuño, J; Pascual, J; Rivera, ME; Teruel, JL; Villafruela, JJ, 2001) |
| "Recent multicenter reports have demonstrated improved outcome in recipients of cadaveric renal transplants treated with mycophenolate mofetil (MMF) versus azathioprine (AZA) in combination with cyclosporine A (CSA) and prednisone." | 3.70 | Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. ( Alfrey, EJ; Dafoe, DC; Lee, CM; Markezich, AJ; Scandling, JD, 1998) |
| " We studied predictive factors of long-term graft survival (up to 9 years) and of kidney graft function at one year after surgery in a single-center population of 468 first cadaveric kidney recipients treated with a uniform immunosuppression induction regimen of anti-thymocyte globulin, followed by cyclosporine A." | 3.69 | Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. ( Ancelet, D; Blancho, G; Cantarovich, D; Dantal, J; Giral, M; Hourmant, M; Nguyen, JM; Soulillou, JP; Taddei, C, 1996) |
| "This paper describes 108 consecutively treated patients receiving 109 cadaveric (CD) and living donor (LD) renal allografts using a protocol of quadruple sequential immunosuppression with a rabbit anti-human thymocyte IgG (Thymoglobuline), azathioprine, tapering corticosteroids, and delayed introduction of cyclosporine A." | 3.69 | Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin. ( Flemming, C; Guttmann, RD, 1997) |
| "One hundred and ninety-two patients received 200 consecutive cadaver renal transplants (158 first and 42 regrafts) and were treated with triple therapy immunosuppression consisting of low-dose cyclosporin, azathioprine and prednisolone." | 3.68 | Triple therapy immunosuppression in cadaveric renal transplantation. ( Higgins, RM; Morris, PJ; Murie, J; Ratcliffe, PJ; Richardson, AJ; Ting, A, 1990) |
| "A retrospective study was carried out in 110 cadaveric kidney transplant recipients to compare the effects of low doses of cyclosporine (CsA), azathioprine (AZP) and steroids (triple-drug therapy) with those of higher doses of steroids plus AZP (conventional immunosuppression)." | 3.68 | The impact of triple drug immunosuppression on clinical results of cadaveric kidney transplantation: a comparison of conventional immunosuppression. ( Fujiwara, T; Kusaka, S; Matsuno, T; Matsuoka, J; Naomoto, Y; Saito, S; Sakagami, K; Shiozaki, S; Takasu, S; Uda, M, 1992) |
| "Triple-therapy (low-dose cyclosporine-azathioprine-prednisone) immunosuppression regimen was compared with double-therapy (cyclosporine-prednisone) in 91 consecutive nonrandomized adult cadaveric renal transplant recipients." | 3.68 | A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation. ( Angstadt, JD; Bowman, JS; Jaffers, GJ; Waymack, JP, 1992) |
| "We compare the results in recipients of cadaveric renal allografts immunosuppressed with cyclosporine and prednisone to those who received immunosuppression with cyclosporine, azathioprine and prednisone." | 3.68 | Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation. ( Martin, DC; Ruzics, E; Tertzakian, G, 1990) |
| "Infectious complications within 1 year of cadaveric kidney transplantation were compared in 45 patients treated with azathioprine, prednisone, and antilymphocyte globulin and 38 patients treated with cyclosporine and prednisone." | 3.67 | Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation. ( Hammer, SM; Monaco, AP; Shaffer, D, 1987) |
| " Therefore, kidney function after cadaveric allograft transplantation was repeatedly determined by renography in 42 patients receiving either high dose cyclosporin A (32 patients) or azathioprine and prednisone (10 patients) until a graft biopsy showed either acute rejection or no rejection within the first 5 postoperative weeks." | 3.67 | Renography and biopsy-verified acute rejection in renal allotransplanted patients receiving cyclosporin A. ( Larsen, S; Løkkegaard, H; Nielsen, SL; Thomsen, HS, 1987) |
| " The patient presented is a 22-year-old white male who, following two renal transplants and prolonged immunosuppressive therapy with azathioprine and methylprednisolone, developed chronic granulocytic leukemia." | 3.66 | Chronic granulocytic leukemia following successful renal transplantation. ( Adler, KR; Lempert, N; Scharfman, WB, 1978) |
| "Eleven of 15 patients with a first acute rejection episode following cadaveric renal transplantation resumed adequate graft function and increased peripheral blood suppressor T-lymphocyte activity following treatment with 'pulse' methylprednisolone and aminophylline (1000mg orally daily for 14 days)." | 3.66 | Suppressor factor in plasma of aminophylline treated renal transplanted patients. ( Servadio, C; Shapira, Z; Shohat, B; Yusim, A, 1983) |
| "Excellent cadaver allograft survival has been achieved with kidneys from cadaver donors pretreated with high intravenously given dosages of cyclophosphamide and intravenous injections of methylprednisolone." | 3.65 | Donor pretreatment in cadaver renal transplantation. ( Woods, JE; Zincke, H, 1977) |
| " Fourteen patients given this material by intramuscular injection after cadaveric renal transplants, in addition to azathioprine and prednisone, had less evidence of rejection compared with patients previously treated with azathioprine and prednisone only, despite a reduction of the mean daily prednisone dose from 65 to 45 mg." | 3.65 | Use of antilymphocyte globulin after cadaveric renal transplantation. ( Dalton, NT; Doak, PB; Meredith, J; Montgomerie, JZ; North, JD, 1969) |
| "Both prednisolone and CsA were associated with slight osteoclast stimulation and osteoblast suppression and marked retardation of mineral apposition and bone formation rates." | 2.71 | Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients. ( Adams, JE; Crowley, V; Cueto-Manzano, AM; France, MW; Freemont, AJ; Gokal, R; Hutchison, AJ; Konel, S; Mawer, B, 2003) |
| "Tacrolimus-treated patients had a lower incidence of hyperlipidemia through 6 months posttransplant." | 2.69 | Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. ( Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield, C; Sorensen, J; Stegall, M; Tolzman, D; van Veldhuisen, P; Wachs, M, 2000) |
| "The Lovastatin treatment did not results in more adverse events than the placebo treatment." | 2.68 | [The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers]. ( Bill, M; Durlik, M; Gaciong, Z; Gradowska, L; Juskowa, J; Lao, M; Paczek, L; Wyzgał, J, 1997) |
| "In group 1, however, a higher number of viral infections and steroid-related side effects was noted." | 2.68 | Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months. ( Aichberger, C; Eberl, T; Königsrainer, A; Margreiter, R; Ofner, D; Pernthaler, H; Riedmann, B, 1996) |
| " In a prospective randomized multicenter trial, 123 patients undergoing acute rejection of cadaveric renal transplants were treated either with OKT3 daily for a mean of 14 days, with concomitant lowering of the dosage of other immunosuppressive drugs (63 patients), or with conventional high-dose steroids (60 patients)." | 2.66 | A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. ( , 1985) |
| "With its incidence of about 40%, acute renal failure (ARF) is a major problem after cadaveric renal transplantation." | 2.66 | Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. ( Berden, JH; Hoitsma, AJ; Koene, RA; Tiggeler, RG; van Lier, HJ; van Valenberg, PL, 1987) |
| " steroid was required, but the steroid dosage requirement then rebounded in the 2 weeks after the end of the prescribed treatment period." | 2.65 | Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen. ( Brodie, JA; Morrell, RM; Rafi, M; Schultz, JR; Wechter, WJ, 1979) |
| " The daily dosage was such as to maintain the rosette-forming cell (RFC) level at 10% of baseline values." | 2.65 | Antithymocyte globulin in cadaver kidney transplantation: a randomized trial based on T-cell monitoring. ( Bach, JF; Crosnier, J; Dandavino, R; Descamps, JM; Kreis, H; Mansouri, R; N'Guyen, AT, 1981) |
| " We conclude from these results (1) that previously the dosage of CyA administered at this centre was probably too high, and (2) early adjustment of dose levels on the basis of blood concentrations and with low-dose prednisone cover appears to be safe and effective, but requires further verification." | 2.65 | Cyclosporin A used alone or in combination with low-dose steroids in cadaveric renal transplantation. ( Brünisholz, M; Brunner, F; Follath, F; Harder, F; Landmann, J; Lörtscher, R; Mihatsch, M; Thiel, G; Wenk, M, 1983) |
| "Data scarcity on DDRTx outcome in diabetic nephropathy (DN) prompted us to review our experience." | 1.38 | Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country. ( Engineer, DP; Godara, SM; Gumber, MR; Jain, SH; Kute, VB; Modi, PR; Munjappa, BC; Patel, HV; Sainaresh, VV; Shah, PR; Shah, VR; Trivedi, HL; Vanikar, AV, 2012) |
| "The azathioprine treated group (AZA group) included 280 patients (132 female) treated for 17,672 months with AZA + Cyclosporine A (CyA) + steroid, or AZA + steroid, while the MMF group included 219 patients (112 female) treated for 5079 months with MMF + CyA + steroid, or MMF + steroid." | 1.33 | Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation? ( Basic-Jukic, N; Brunetta, B; Bubic-Filipi, LJ; Kes, P; Pasini, J; Puretic, Z, 2005) |
| "The mortality rate of acute pancreatitis is much higher in immunosuppressed patients." | 1.31 | [Acute pancreatitis after kidney transplantation]. ( Asztalos, L; Balzs, G; Berczi, C; Fedor, R; Kincses, Z; Locsey, L; Szabo, L, 2001) |
| "The long-term side effects of lifelong steroid immunosuppression are well documented, therefore, steroid withdrawal (SW) if safe would clearly be of benefit." | 1.30 | Steroid withdrawal in kidney transplant recipients: is it a safe option? ( Haussman, G; Isaacs, I; Ishitani, M; Lobo, P; McCullough, C; Pruett, T; Sanfey, H, 1997) |
| "The data show that patients with ESRD secondary to lupus nephritis can undergo renal transplantation with satisfactory outcome." | 1.29 | Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases. ( Aswad, S; Bangsil, R; el-Shahawy, MA; Massry, SG; Mendez, R; Mendez, RG, 1995) |
| "Nifedipine was selected over verapamil or diltiazem due to its lack of interference with the metabolism of CsA." | 1.29 | Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. ( Adubor, C; Cheigh, JS; Fotino, M; Friedman, GS; Haschemeyer, RH; Riggio, RR; Saal, SD; Stubenbord, WT; Suthanthiran, M; Wang, JC, 1993) |
| " A decrease in or cessation of cyclosporine dosage frequently is used in an attempt to minimize nephrotoxicity." | 1.28 | Highly sensitized patients with delayed graft function: a management protocol. ( Hakala, TR; Hickey, DP; Hrebinko, R; Jordan, ML; Lopatin, WB; O'Donovan, R; Vivas, CA, 1991) |
| " in the same dosage in combination with heparin 5000 U/day." | 1.26 | Treatment of acute allograft rejection with high doses of corticosteroids. ( Alarcon-Zurita, A; Ladefoged, J, 1976) |
| " The major defect was depressed granulocyte adherence early postoperatively and at the time of rejection crises, when prednisone dosage was maximal." | 1.26 | Granulocyte function in recipients of renal transplant from live related donors and from cadavers. ( Barker, CF; Golshan, N; MacGregor, RR, 1980) |
| " Serious complications and mortality could be related to high dosage of steroids and severe leukopenia." | 1.26 | Influence of rejection on graft survival after renal transplantation. ( Black, HR; Finkelstein, FO; Lytton, B; Schiff, M, 1976) |
| "Norwegian scabies is rare yet distinctive." | 1.26 | Norwegian scabies: occurrence in a patient undergoing immunosuppression. ( Espy, PD; Jolly, HW, 1976) |
| "Signs of spinal cord compression evolved." | 1.26 | Aspergillus fumigatus epidural abscess in a renal transplant recipient. ( Ingwer, I; McLeish, KR; Tight, RR; White, AC, 1978) |
| "Chronic granulocytic leukemia developed four years after renal transplantation in a patient, who had been treated with immunosuppressive agents since then." | 1.26 | Chronic granulocytic leukemia in a renal transplant recipient. ( Hagenouw-Taal, JC; Lameijer, LD; Mooy, JM; van Turnhout, JM, 1978) |
| "The requirement for insulin decreased in both patients during the period of renal insufficiency and increased following transplantation; this seemed to be related to the large dose of steroids given because now that a maintenance level of steroids has been established, both patients require the same dosage of insulin as they did before the onset of renal insufficiency." | 1.25 | Treatment of renal failure from diabetic nephropathy with cadaveric homograft. ( Beaudry, C; Laplate, L, 1973) |
| " Statistical analysis showed that the association of leucopenia and trimethoprim-sulphamethoxazole therapy was dependent on the time after the transplantation procedure and was not related to the dosage of immunosuppressive chemotherapy or renal function." | 1.25 | Leucopenia associated with trimethoprim-sulphamethoxazole after renal transplantation. ( Hulme, B; Reeves, DS, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 275 (64.55) | 18.7374 |
| 1990's | 112 (26.29) | 18.2507 |
| 2000's | 38 (8.92) | 29.6817 |
| 2010's | 1 (0.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tekgündüz, E | 1 |
| Apaydin, S | 1 |
| Seyahi, N | 1 |
| Altiparmak, MR | 1 |
| Kute, VB | 1 |
| Godara, SM | 1 |
| Shah, PR | 1 |
| Jain, SH | 1 |
| Engineer, DP | 1 |
| Patel, HV | 1 |
| Gumber, MR | 1 |
| Munjappa, BC | 1 |
| Sainaresh, VV | 1 |
| Vanikar, AV | 1 |
| Modi, PR | 1 |
| Shah, VR | 1 |
| Trivedi, HL | 1 |
| Ushigome, H | 2 |
| Okamoto, M | 2 |
| Kadotani, Y | 2 |
| Nakamura, K | 2 |
| Akioka, K | 2 |
| Ohmori, Y | 2 |
| Yoshimura, N | 2 |
| Ojogho, ON | 1 |
| Sahney, S | 1 |
| Cutler, D | 1 |
| Baron, PW | 1 |
| Abdelhalim, FM | 1 |
| Hasan, SM | 1 |
| Concepcion, W | 1 |
| Nishikawa, K | 1 |
| Terasaki, PI | 3 |
| Nobori, S | 1 |
| Higuchi, A | 1 |
| Gentil, MA | 1 |
| Alcaide, MP | 1 |
| Algarra, GR | 1 |
| Pereira, P | 1 |
| Toro, J | 1 |
| González-Roncero, F | 1 |
| López, M | 1 |
| Bernal, G | 1 |
| Mateos, J | 1 |
| Tedesco Silva, H | 1 |
| Felipe, CR | 1 |
| Machado, PG | 1 |
| Garcia, R | 1 |
| Motegi, S | 1 |
| Hosaka, BH | 1 |
| Hanzawa, NM | 1 |
| Park, SI | 1 |
| Casarini, D | 1 |
| Lima, VC | 1 |
| Franco, M | 1 |
| Medina-Pestana, JO | 1 |
| Schnitzler, MA | 1 |
| Craig, KE | 1 |
| Hardinger, KE | 1 |
| Lowell, JA | 1 |
| Brennan, DC | 1 |
| Gonwa, T | 3 |
| Johnson, C | 3 |
| Ahsan, N | 3 |
| Alfrey, EJ | 3 |
| Halloran, P | 4 |
| Stegall, M | 3 |
| Hardy, M | 3 |
| Metzger, R | 3 |
| Shield, C | 2 |
| Rocher, L | 3 |
| Scandling, J | 3 |
| Sorensen, J | 3 |
| Mulloy, L | 3 |
| Light, J | 3 |
| Corwin, C | 3 |
| Danovitch, G | 3 |
| Wachs, M | 3 |
| VanVeldhuisen, P | 2 |
| Leonhardt, M | 1 |
| Fitzsimmons, WE | 3 |
| Cueto-Manzano, AM | 1 |
| Konel, S | 1 |
| Crowley, V | 1 |
| France, MW | 1 |
| Freemont, AJ | 1 |
| Adams, JE | 1 |
| Mawer, B | 1 |
| Gokal, R | 3 |
| Hutchison, AJ | 1 |
| Cherikh, WS | 1 |
| Myron Kauffman, H | 1 |
| Maghirang, J | 1 |
| Bleyer, AJ | 1 |
| Johnson, CP | 3 |
| DUNEA, G | 1 |
| NAKAMOTO, S | 7 |
| STRAFFON, RA | 7 |
| FIGUEROA, JE | 1 |
| VERSACI, AA | 1 |
| SHIBAGAKI, M | 1 |
| KOLFF, WJ | 5 |
| DOSSETOR, JB | 3 |
| GAULT, MH | 2 |
| OLIVER, JA | 1 |
| INGLIS, FG | 1 |
| MACKINNON, KJ | 1 |
| MACLEAN, LD | 1 |
| HUME, DM | 4 |
| MAGEE, JH | 1 |
| PROUT, GR | 2 |
| KAUFFMAN, HM | 2 |
| CLEVELAND, RH | 1 |
| BOWER, JD | 1 |
| LEE, HM | 6 |
| Castelao, AM | 3 |
| Griño, JM | 2 |
| Sabate, I | 2 |
| Seron, D | 2 |
| Andres, E | 2 |
| Gilvernet, S | 1 |
| Bover, J | 1 |
| Gonzalez, C | 1 |
| Alsina, J | 2 |
| Hazzan, M | 1 |
| Provot, F | 1 |
| Glowacki, F | 1 |
| Copin, MC | 1 |
| Roumilhac, D | 1 |
| Labalette, M | 1 |
| Pruvot, FR | 1 |
| Noel, C | 1 |
| Joh, JW | 1 |
| Lee, HH | 1 |
| Lee, DS | 1 |
| Lee, KW | 1 |
| Lee, SK | 1 |
| Kim, SJ | 1 |
| Chuang, P | 1 |
| Parikh, CR | 1 |
| Langone, A | 1 |
| Basic-Jukic, N | 1 |
| Kes, P | 1 |
| Bubic-Filipi, LJ | 1 |
| Puretic, Z | 1 |
| Brunetta, B | 1 |
| Pasini, J | 1 |
| Oliveira, JG | 1 |
| Monteiro, MS | 1 |
| Teixeira, JF | 1 |
| Osório, E | 1 |
| Norton, SM | 1 |
| Alves, H | 1 |
| Pestana, M | 1 |
| Ichikawa, Y | 2 |
| Kishikawa, H | 1 |
| Nishimura, K | 1 |
| Tokugawa, S | 1 |
| Yoshioka, I | 1 |
| Arichi, N | 1 |
| Fujii, N | 1 |
| Kyo, M | 2 |
| Nishikawa, M | 1 |
| Kahu, J | 1 |
| Lõhmus, A | 1 |
| Ilmoja, M | 1 |
| Kirsimägi, U | 1 |
| Timberg, G | 1 |
| Peetsalu, A | 1 |
| Kahan, BD | 4 |
| Van Buren, CT | 4 |
| Lin, SN | 1 |
| Ono, Y | 1 |
| Agostino, G | 1 |
| LeGrue, SJ | 1 |
| Boileau, M | 2 |
| Payne, WD | 4 |
| Kerman, RH | 4 |
| Shapira, Z | 1 |
| Shohat, B | 1 |
| Yusim, A | 1 |
| Servadio, C | 1 |
| Novick, AC | 5 |
| Braun, WE | 2 |
| Steinmuller, D | 3 |
| Buszta, C | 3 |
| Greenstreet, R | 1 |
| Kiser, W | 1 |
| Barry, JM | 5 |
| Larson, B | 1 |
| Fischer, SM | 1 |
| Norman, DJ | 4 |
| Bennett, WM | 6 |
| Sommer, BG | 3 |
| Ferguson, RM | 4 |
| Najarian, JS | 9 |
| Hoyer, PF | 1 |
| Offner, G | 1 |
| Brodehl, J | 1 |
| Starzl, TE | 9 |
| Rosenthal, JT | 7 |
| Hakala, TR | 4 |
| Iwatsuki, S | 5 |
| Shaw, BW | 3 |
| Klintmalm, GB | 1 |
| Mittal, VK | 1 |
| Toledo-Pereyra, LH | 3 |
| Baskin, S | 2 |
| McNichol, LJ | 1 |
| Thavarajah, K | 1 |
| Lin, W | 1 |
| Edford, G | 2 |
| Whitten, J | 2 |
| Allaben, R | 2 |
| Thiel, G | 4 |
| Harder, F | 1 |
| Lörtscher, R | 1 |
| Brünisholz, M | 1 |
| Landmann, J | 4 |
| Brunner, F | 2 |
| Follath, F | 1 |
| Wenk, M | 1 |
| Mihatsch, M | 3 |
| Starzl, T | 1 |
| Merion, RM | 1 |
| White, DJ | 1 |
| Thiru, S | 2 |
| Evans, DB | 4 |
| Calne, RY | 5 |
| Khauli, RB | 2 |
| Cunningham, R | 1 |
| Goormastic, M | 2 |
| d'Apice, AJ | 3 |
| Becker, GJ | 1 |
| Kincaid-Smith, P | 1 |
| Mathew, TH | 4 |
| Ng, J | 1 |
| Hardie, IR | 3 |
| Petrie, JJ | 2 |
| Rigby, RJ | 3 |
| Dawborn, J | 1 |
| Heale, WF | 1 |
| Madsen, S | 1 |
| Kristensen, JK | 1 |
| Langhoff, E | 1 |
| Olgaard, K | 1 |
| Ladefoged, J | 2 |
| Thaysen, JH | 2 |
| Vanrenterghem, Y | 3 |
| Waer, M | 3 |
| Ang, K | 1 |
| van der Schueren, E | 1 |
| Gruwez, J | 2 |
| Bouillon, R | 1 |
| Michielsen, P | 2 |
| Sutherland, DE | 5 |
| Chinn, PL | 1 |
| Goetz, FC | 1 |
| Elick, BA | 1 |
| Kovithavongs, T | 1 |
| Boake, R | 1 |
| Lakey, WH | 1 |
| Ulan, RA | 1 |
| Tilney, NL | 3 |
| Milford, EL | 2 |
| Araujo, JL | 1 |
| Strom, TB | 2 |
| Carpenter, CB | 4 |
| Kirkman, RL | 2 |
| Grundmann, R | 2 |
| Wienand, P | 2 |
| Meider, G | 1 |
| Vlaho, V | 1 |
| Pichlmaier, H | 3 |
| Papadakis, J | 1 |
| Brown, CB | 1 |
| Cameron, JS | 1 |
| Adu, D | 1 |
| Bewick, M | 2 |
| Donaghey, R | 1 |
| Ogg, CS | 2 |
| Rudge, C | 1 |
| Williams, DG | 1 |
| Taube, D | 1 |
| Dandavino, R | 2 |
| Barcelo, R | 1 |
| Beaudry, C | 2 |
| Cardinal, J | 1 |
| Carriere, S | 1 |
| Friborg, J | 1 |
| Houde, M | 1 |
| Ouimet, D | 1 |
| Bastien, E | 1 |
| Girard, R | 1 |
| Laplante, L | 1 |
| MacSween, JM | 1 |
| Cohen, AD | 2 |
| Rajaraman, K | 1 |
| Fox, RA | 1 |
| Dumler, F | 2 |
| Levin, NW | 3 |
| Szego, G | 1 |
| Vulpetti, AT | 1 |
| Preuss, LE | 1 |
| McGeown, MG | 3 |
| Douglas, JF | 2 |
| Brown, WA | 1 |
| Donaldson, RA | 2 |
| Kennedy, JA | 2 |
| Loughridge, WG | 2 |
| Mehta, S | 1 |
| Nelson, SD | 1 |
| Doherty, CC | 1 |
| Johnstone, R | 1 |
| Todd, G | 1 |
| Hill, CM | 2 |
| Pollak, R | 2 |
| Nishikawa, RA | 1 |
| Mozes, MF | 2 |
| Jonasson, O | 1 |
| Renna, E | 1 |
| Alfani, D | 1 |
| Monari, C | 1 |
| Trovati, A | 1 |
| Berloco, P | 1 |
| Famulari, A | 1 |
| Cucchiara, G | 1 |
| Cortesini, R | 1 |
| Golshan, N | 1 |
| Barker, CF | 1 |
| MacGregor, RR | 1 |
| Kreis, H | 2 |
| Mansouri, R | 1 |
| Descamps, JM | 1 |
| N'Guyen, AT | 1 |
| Bach, JF | 2 |
| Crosnier, J | 2 |
| Frankus, E | 1 |
| McNichol, L | 1 |
| Shapiro, R | 1 |
| Jordan, M | 1 |
| Scantlebury, V | 1 |
| Vivas, C | 1 |
| Fung, J | 1 |
| McCauley, J | 1 |
| Tzakis, A | 1 |
| Randhawa, P | 1 |
| Demetris, AJ | 1 |
| Irish, W | 1 |
| Abbud-Filho, M | 1 |
| Ramalho, H | 1 |
| Barberato, JB | 1 |
| Silva, ML | 1 |
| Yamazaki, W | 1 |
| Salgueiro, MC | 1 |
| Zerati-Fo, M | 1 |
| D'Avila, CL | 1 |
| Bezas, AG | 1 |
| el-Shahawy, MA | 1 |
| Aswad, S | 1 |
| Mendez, RG | 1 |
| Bangsil, R | 1 |
| Mendez, R | 3 |
| Massry, SG | 1 |
| Wilson, JM | 1 |
| Baker, SP | 1 |
| Valliere, SA | 1 |
| Lovewell, TD | 1 |
| Stoff, JS | 1 |
| Kahn, D | 1 |
| Ovnat, A | 1 |
| Pontin, AR | 1 |
| Swanepoel, CR | 1 |
| Cassidy, MJ | 1 |
| Christiaans, M | 1 |
| Van den Berg-Loonen, E | 1 |
| Ten Haaft, A | 1 |
| Nieman, F | 1 |
| Van Hooff, J | 1 |
| Lee, HA | 2 |
| Slapak, M | 4 |
| Raman, GV | 1 |
| Mason, JC | 1 |
| Digard, N | 4 |
| Wise, M | 2 |
| Vathsala, A | 2 |
| Lee, WT | 1 |
| Li, MK | 1 |
| Woo, KT | 2 |
| Lim, CH | 2 |
| Hoshinaga, K | 3 |
| Fujita, T | 1 |
| Naide, Y | 3 |
| Akutsu, H | 1 |
| Sasaki, H | 1 |
| Tsukiashi, Y | 2 |
| Nishiyama, N | 1 |
| Yanaoka, M | 2 |
| Shinoda, M | 1 |
| Kanno, T | 1 |
| Isoniemi, H | 2 |
| Kyllönen, L | 1 |
| Eklund, B | 2 |
| Höckerstedt, K | 2 |
| Salmela, K | 2 |
| von Willebrand, E | 1 |
| Ahonen, J | 2 |
| Bock, A | 2 |
| Spöndlin, M | 1 |
| Brunner, FP | 2 |
| Rufli, T | 1 |
| Carmellini, M | 3 |
| Romagnoli, J | 1 |
| Pietrabissa, A | 1 |
| Di Stefano, R | 1 |
| Oleggini, M | 1 |
| Rindi, P | 1 |
| Rizzo, G | 3 |
| Mosca, F | 1 |
| Aikawa, A | 1 |
| Sells, RA | 1 |
| Bakran, A | 3 |
| Tewari, A | 1 |
| Sato, K | 3 |
| Tadokoro, F | 1 |
| Ishida, K | 1 |
| Matsuzawa, K | 1 |
| Nakayama, Y | 2 |
| Yokota, K | 2 |
| Kakita, A | 1 |
| Kumano, K | 2 |
| Endo, T | 2 |
| Takeuchi, Y | 1 |
| Vereerstraeten, P | 4 |
| Abramowicz, D | 3 |
| Doutrelepont, JM | 1 |
| De Pauw, L | 4 |
| Kinnaert, P | 4 |
| Sokolova, TIu | 1 |
| Pronchenko, IA | 1 |
| Biriukova, LS | 1 |
| Sevost'ianov, VA | 1 |
| Ermakova, IP | 1 |
| Koyama, H | 1 |
| Cecka, JM | 1 |
| Slakey, DP | 2 |
| Callaluce, RD | 2 |
| Browne, BJ | 2 |
| Zhu, YR | 1 |
| Roza, AM | 2 |
| Adams, MB | 2 |
| Slaton, JW | 1 |
| Kropp, KA | 1 |
| Jhunjhunwala, JS | 1 |
| Selman, SH | 1 |
| Venkatraman, G | 1 |
| Mason, J | 1 |
| Hashimoto, M | 1 |
| Sata, M | 1 |
| Fujimoto, N | 1 |
| Kinoshita, T | 1 |
| Kanda, H | 1 |
| Ishibashi, M | 1 |
| Fukunishi, T | 1 |
| Amemiya, H | 2 |
| Khan, IH | 1 |
| Kernohan, NM | 1 |
| Catto, GR | 1 |
| Edward, N | 1 |
| Venkat, KK | 2 |
| Kupin, W | 1 |
| Gracida, C | 1 |
| Uniewski, M | 1 |
| Anaise, D | 1 |
| Tang, DH | 1 |
| Tiller, DJ | 5 |
| Mahony, JF | 1 |
| Miach, PJ | 1 |
| Thomson, NM | 1 |
| Thatcher, GN | 1 |
| Menzies, BL | 1 |
| Opelz, G | 3 |
| Cantarovich, D | 3 |
| Baranger, T | 1 |
| Tirouvanziam, A | 1 |
| Baatard, R | 1 |
| Le Sant, JN | 1 |
| Dantal, J | 2 |
| Hourmant, M | 2 |
| Karam, G | 1 |
| Soulillou, JP | 2 |
| Bergmann, LS | 1 |
| Roper, L | 4 |
| Bow, LM | 1 |
| Hull, D | 3 |
| Bartus, SA | 2 |
| Schweizer, RT | 4 |
| Sheil, AG | 6 |
| Disney, AP | 3 |
| Amiss, N | 2 |
| Howard, RJ | 1 |
| Pfaff, WW | 1 |
| Brunson, ME | 1 |
| Ramos, EL | 1 |
| Peterson, JC | 1 |
| Croker, BP | 1 |
| Scornik, JC | 1 |
| Parris, CJ | 1 |
| Fennell, RS | 1 |
| Suthanthiran, M | 1 |
| Haschemeyer, RH | 1 |
| Riggio, RR | 2 |
| Adubor, C | 1 |
| Friedman, GS | 1 |
| Cheigh, JS | 2 |
| Wang, JC | 1 |
| Fotino, M | 1 |
| Stubenbord, WT | 1 |
| Saal, SD | 1 |
| Ciancio, G | 2 |
| Rosen, A | 1 |
| Loreto-Grand, B | 1 |
| Burke, G | 1 |
| Siquijor, A | 1 |
| Luque, C | 1 |
| Esquenazi, V | 2 |
| Miller, J | 4 |
| Haberal, M | 2 |
| Bilgin, N | 1 |
| Karakayali, H | 2 |
| Arslan, G | 1 |
| Büyükpamukçu, N | 1 |
| Velidedeoğlu, E | 1 |
| Turan, M | 1 |
| Akkoç, H | 2 |
| Moray, G | 2 |
| Tezel, E | 1 |
| Shield, CF | 2 |
| Jacobs, RJ | 1 |
| Wyant, S | 1 |
| Das, A | 1 |
| Kehinde, EO | 1 |
| Wheatley, T | 1 |
| Feehally, J | 1 |
| Nicholson, ML | 1 |
| Veitch, PS | 1 |
| Bell, PR | 2 |
| Han, DJ | 2 |
| Yoon, HS | 1 |
| Yokoyama, I | 2 |
| Hayashi, S | 1 |
| Kobayashi, T | 1 |
| Negita, M | 1 |
| Katayama, A | 1 |
| Nagasaka, R | 1 |
| Namii, Y | 1 |
| Kojima, T | 1 |
| Koike, C | 1 |
| Uchida, K | 2 |
| Takagi, H | 2 |
| Shiroki, R | 2 |
| Higuchi, T | 2 |
| Horiba, Y | 1 |
| Xiwen, B | 1 |
| Lixin, Y | 1 |
| Junjie, M | 1 |
| Aichberger, C | 1 |
| Eberl, T | 1 |
| Riedmann, B | 1 |
| Pernthaler, H | 1 |
| Ofner, D | 1 |
| Königsrainer, A | 3 |
| Margreiter, R | 3 |
| Ratcliffe, PJ | 2 |
| Dudley, CR | 1 |
| Higgins, RM | 2 |
| Firth, JD | 1 |
| Smith, B | 1 |
| Morris, PJ | 3 |
| Peeters, J | 1 |
| Christiaens, MR | 1 |
| Coosemans, W | 1 |
| Donck, J | 1 |
| Roels, L | 2 |
| Verberckmoes, R | 1 |
| Louis-Touizer, C | 1 |
| Nuijten, MJ | 1 |
| Bayle, F | 1 |
| Lang, P | 1 |
| Lebranchu, Y | 1 |
| Le Pogamp, P | 1 |
| Touraine, JL | 1 |
| Vialtel, P | 1 |
| Monroe, T | 1 |
| de Vries, MJ | 1 |
| Kyriakopoulos, G | 1 |
| Antoniadis, A | 1 |
| Gakis, D | 1 |
| Papanikolaou, V | 1 |
| Vazquez, MC | 1 |
| Sabbatiello, R | 1 |
| Schiavelli, R | 1 |
| Maiolo, E | 1 |
| Jacob, N | 1 |
| Pattin, M | 1 |
| Rearte, A | 1 |
| Guttmann, RD | 5 |
| Flemming, C | 1 |
| Woodle, ES | 1 |
| Newell, KA | 1 |
| Haas, M | 1 |
| Bartosh, S | 1 |
| Josephson, MA | 1 |
| Millis, JM | 1 |
| Bruce, DS | 1 |
| Piper, JB | 1 |
| Aronson, AJ | 1 |
| Thistlethwaite, JR | 1 |
| Giral, M | 1 |
| Taddei, C | 1 |
| Nguyen, JM | 1 |
| Blancho, G | 1 |
| Ancelet, D | 1 |
| Craig, WJ | 1 |
| Paczek, L | 2 |
| Bill, M | 1 |
| Wyzgał, J | 1 |
| Gaciong, Z | 1 |
| Gradowska, L | 2 |
| Juskowa, J | 1 |
| Durlik, M | 1 |
| Lao, M | 2 |
| Sullivan, SD | 1 |
| Garrison, LP | 1 |
| Best, JH | 1 |
| Drafts, HH | 1 |
| Anjum, MR | 1 |
| Wynn, JJ | 1 |
| Mulloy, LL | 1 |
| Bowley, JN | 1 |
| Humphries, AL | 1 |
| Xenos, EX | 1 |
| Burke, GW | 1 |
| Roth, D | 1 |
| Sanfey, H | 1 |
| Haussman, G | 1 |
| Isaacs, I | 1 |
| Ishitani, M | 1 |
| Lobo, P | 1 |
| McCullough, C | 1 |
| Pruett, T | 1 |
| Johnson, EM | 1 |
| Canafax, DM | 4 |
| Gillingham, KJ | 1 |
| Humar, A | 2 |
| Pandian, K | 1 |
| Kerr, SR | 1 |
| Matas, AJ | 4 |
| Izumitani, M | 1 |
| Horiba, M | 1 |
| Weber, M | 1 |
| Deng, S | 1 |
| Arenas, J | 1 |
| Aradhye, S | 1 |
| Grossman, R | 1 |
| Shaw, L | 1 |
| Naji, A | 2 |
| Barker, C | 1 |
| Brayman, KL | 1 |
| Morris-Stiff, G | 1 |
| Singh, J | 1 |
| Balaji, V | 1 |
| Ostrowski, K | 1 |
| Webley, Y | 1 |
| Moore, R | 1 |
| Lord, R | 1 |
| Jurewicz, WA | 1 |
| Peddi, VR | 1 |
| Whiting, J | 1 |
| Weiskittel, PD | 1 |
| Alexander, JW | 2 |
| First, MR | 3 |
| Lee, CM | 1 |
| Markezich, AJ | 1 |
| Scandling, JD | 1 |
| Dafoe, DC | 2 |
| Demirağ, A | 1 |
| Kaden, J | 2 |
| Strobelt, V | 3 |
| May, G | 4 |
| Baker, GM | 1 |
| Martin, JE | 1 |
| Jang, R | 1 |
| Schroeder, TJ | 1 |
| Armitstead, JA | 1 |
| Myre, S | 1 |
| Wissing, M | 1 |
| Raofi, V | 1 |
| Holman, DM | 1 |
| Coady, N | 1 |
| Vazquez, E | 1 |
| Dunn, TB | 1 |
| Bartholomew, AM | 1 |
| Benedetti, E | 1 |
| Ponticelli, C | 6 |
| Tarantino, A | 5 |
| Segoloni, GP | 2 |
| Cambi, V | 2 |
| Altieri, P | 2 |
| Mastrangelo, F | 2 |
| Castagneto, M | 2 |
| Salvadori, M | 2 |
| Valente, U | 1 |
| Cossu, M | 2 |
| Federico, S | 1 |
| Pisani, F | 2 |
| Montagnino, G | 5 |
| Messina, M | 1 |
| Arisi, L | 1 |
| Piredda, G | 1 |
| Corbetta, G | 1 |
| van Veldhuisen, P | 1 |
| Salm, K | 2 |
| Tolzman, D | 2 |
| Pirsch, JD | 3 |
| Jensik, SC | 1 |
| Maccario, M | 1 |
| Elli, A | 2 |
| Cesana, B | 1 |
| Nowacka-Cieciura, E | 1 |
| Kamiñska, B | 1 |
| Cieciura, T | 1 |
| Pazik, J | 1 |
| Rowiñski, W | 2 |
| Quarto di Palo, F | 1 |
| Rivolta, R | 1 |
| Aroldi, A | 1 |
| Shimada, H | 1 |
| Sakamoto, K | 1 |
| Hori, S | 1 |
| Asano, T | 1 |
| Suzuki, T | 1 |
| Gunji, Y | 1 |
| Nakajima, K | 1 |
| Kenmochi, T | 1 |
| Hayashi, H | 1 |
| Takeda, A | 1 |
| Arita, S | 1 |
| Kashiwabara, H | 1 |
| Yokoyama, T | 1 |
| Ochiai, T | 1 |
| Jang, HJ | 1 |
| Kim, SC | 1 |
| Wong, KM | 1 |
| Cheung, CY | 1 |
| Chan, YH | 1 |
| Chak, WL | 1 |
| Choi, KS | 1 |
| Chau, KF | 1 |
| Li, CS | 1 |
| Toda, F | 1 |
| Tanabe, K | 1 |
| Tokumoto, T | 1 |
| Ishikawa, N | 1 |
| Koga, S | 1 |
| Ito, S | 1 |
| Yagisawa, T | 2 |
| Toma, H | 2 |
| Arrazola, L | 1 |
| Sozen, H | 1 |
| Papalois, V | 1 |
| Uknis, M | 1 |
| Zhou, PJ | 1 |
| Tang, XD | 1 |
| Wang, XH | 1 |
| Xu, D | 1 |
| Siu, CW | 1 |
| Chan, TM | 1 |
| Li, FK | 1 |
| Choy, BY | 1 |
| Lui, SL | 1 |
| Lo, CY | 1 |
| Tang, S | 1 |
| Lo, WK | 1 |
| Lai, KN | 1 |
| Jirasiritham, S | 1 |
| Sumethkul, V | 1 |
| Mavichak, V | 1 |
| Chalermsanyakorn, P | 1 |
| Asztalos, L | 1 |
| Kincses, Z | 1 |
| Berczi, C | 1 |
| Szabo, L | 1 |
| Fedor, R | 1 |
| Locsey, L | 1 |
| Balzs, G | 1 |
| Marcén, R | 1 |
| Pascual, J | 2 |
| Teruel, JL | 1 |
| Villafruela, JJ | 1 |
| Rivera, ME | 1 |
| Mampaso, F | 1 |
| Burgos, FJ | 1 |
| Ortuño, J | 2 |
| Shield , C | 1 |
| Ferrara, R | 1 |
| Szymczakiewicz-Multanowska, AM | 1 |
| Kuźniewski, M | 1 |
| Zawilińska, B | 1 |
| Zgórniak-Nowosielska, I | 1 |
| Uracz, D | 1 |
| Ignacak, E | 1 |
| Betkowska-Prokop, A | 1 |
| Sułowicz, W | 1 |
| Calmus, Y | 1 |
| Scheele, JR | 1 |
| Gonzalez-Pinto, I | 1 |
| Jaurrieta, EJ | 1 |
| Klar, E | 1 |
| Pageaux, GP | 1 |
| Scudamore, CH | 1 |
| Cuervas-Mons, V | 1 |
| Metselaar, HJ | 1 |
| Prestele, H | 1 |
| Girault, D | 1 |
| Landis, TF | 1 |
| von Felten, A | 1 |
| Berchtold, H | 1 |
| Guttman, RD | 1 |
| Beaudoin, JG | 5 |
| Morehouse, DD | 3 |
| Klassen, J | 1 |
| Knaack, J | 3 |
| Jeffery, J | 1 |
| Chassot, PG | 3 |
| Abbou, CC | 1 |
| Zincke, H | 1 |
| Woods, JE | 1 |
| Ingwer, I | 1 |
| McLeish, KR | 1 |
| Tight, RR | 1 |
| White, AC | 1 |
| Mooy, JM | 1 |
| Hagenouw-Taal, JC | 1 |
| Lameijer, LD | 1 |
| van Turnhout, JM | 1 |
| Adler, KR | 1 |
| Lempert, N | 1 |
| Scharfman, WB | 1 |
| Jeffery, JR | 1 |
| Downs, A | 1 |
| Grahame, JW | 1 |
| Lye, C | 1 |
| Ramsey, E | 1 |
| Thomson, AE | 1 |
| Groth, CG | 9 |
| Berg, B | 1 |
| Collste, H | 1 |
| Lundgren, G | 1 |
| Magnusson, G | 1 |
| Ringdén, O | 1 |
| Pieper, R | 1 |
| Butt, KM | 1 |
| Zielinski, CM | 1 |
| Parsa, I | 1 |
| Elberg, AJ | 1 |
| Wechter, W | 1 |
| Kountz, SL | 3 |
| Wechter, WJ | 1 |
| Brodie, JA | 1 |
| Morrell, RM | 2 |
| Rafi, M | 1 |
| Schultz, JR | 1 |
| Schmidt, P | 1 |
| Kopsa, H | 1 |
| Balcke, P | 1 |
| Zazgornik, J | 1 |
| Pils, P | 1 |
| Alarcon-Zurita, A | 1 |
| Jessing, P | 1 |
| Agger, B | 1 |
| Pedersen, FB | 1 |
| Cosimi, AB | 3 |
| Wortis, HH | 1 |
| Delmonico, FL | 2 |
| Russell, PS | 3 |
| Casali, R | 1 |
| Simmons, RL | 3 |
| Mauer, MM | 1 |
| Kjellstrand, CM | 2 |
| Buselmeier, TJ | 1 |
| Lytton, B | 1 |
| Finkelstein, FO | 1 |
| Schiff, M | 1 |
| Black, HR | 1 |
| Oppolzer, R | 1 |
| Stummvoll, H | 1 |
| Wolf, A | 1 |
| Pinggera, W | 1 |
| Rai, GS | 1 |
| Wilkinson, R | 1 |
| Elliott, RW | 1 |
| Uldall, PR | 1 |
| Taylor, RM | 1 |
| McDonald, FD | 2 |
| Horensten, ML | 1 |
| Mayor, GB | 1 |
| Turcotte, JG | 2 |
| Selezinka, W | 1 |
| Schork, MA | 1 |
| Espy, PD | 1 |
| Jolly, HW | 1 |
| Lawson, RK | 3 |
| Talwalkar, YB | 1 |
| Musgrave, JE | 1 |
| Campbell, RA | 2 |
| Hodges, CV | 3 |
| Kaplan, BS | 1 |
| Morehouse, D | 2 |
| Bowman, JS | 1 |
| Angstadt, JD | 1 |
| Waymack, JP | 1 |
| Jaffers, GJ | 1 |
| Fellmann, T | 1 |
| Rosman, J | 1 |
| Lindholm, A | 3 |
| Albrechtsen, D | 2 |
| Tufveson, G | 1 |
| Karlberg, I | 1 |
| Persson, NH | 1 |
| Rauff, A | 1 |
| Asano, H | 1 |
| Tominaga, Y | 1 |
| Haba, T | 1 |
| Numano, M | 1 |
| Orihara, A | 1 |
| Bućin, D | 1 |
| Ekberg, H | 1 |
| Persson, H | 1 |
| Tufvesson, G | 1 |
| Pallardó, LM | 1 |
| Sánchez, J | 1 |
| Sánchez, P | 1 |
| García, J | 1 |
| Orero, E | 1 |
| Beneyto, I | 1 |
| Ros, F | 1 |
| Egerer, K | 1 |
| Schreiner, S | 1 |
| Wesslau, C | 1 |
| Schönemann, C | 1 |
| Egerer, B | 1 |
| Krogerus, L | 1 |
| Häyry, P | 1 |
| Sampaio, M | 1 |
| Ianhez, LE | 1 |
| Sabbaga, E | 1 |
| Ettenger, R | 1 |
| Marik, J | 4 |
| Isa, WA | 1 |
| Robles, JE | 1 |
| Rosell, D | 1 |
| Aguera, LG | 1 |
| de Castro, F | 1 |
| Sanchez, PL | 1 |
| Zudaire, JJ | 1 |
| Errasti, P | 1 |
| Berian, JM | 1 |
| Vilardell, J | 1 |
| Oppenheimer, F | 1 |
| Puig, JM | 1 |
| Cantarell, MC | 1 |
| Solá, R | 1 |
| Lauzurica, R | 1 |
| Sakagami, K | 1 |
| Saito, S | 1 |
| Shiozaki, S | 1 |
| Takasu, S | 1 |
| Matsuno, T | 1 |
| Fujiwara, T | 1 |
| Kusaka, S | 1 |
| Uda, M | 1 |
| Matsuoka, J | 1 |
| Naomoto, Y | 1 |
| Brazy, PC | 1 |
| Belzer, FO | 5 |
| Gaston, RS | 2 |
| Hudson, SL | 2 |
| Deierhoi, MH | 4 |
| Barber, WH | 3 |
| Laskow, DA | 2 |
| Julian, BA | 2 |
| Curtis, JJ | 2 |
| Barger, BO | 2 |
| Shroyer, TW | 1 |
| Diethelm, AG | 3 |
| Schaffner, A | 1 |
| Thomann, B | 1 |
| Zala, GF | 1 |
| Rüegg, R | 1 |
| Keusch, G | 2 |
| Fehr, J | 1 |
| Gmür, J | 1 |
| Hickey, DP | 1 |
| Vivas, CA | 1 |
| Jordan, ML | 2 |
| Lopatin, WB | 1 |
| Hrebinko, R | 1 |
| O'Donovan, R | 1 |
| Ettenger, RB | 3 |
| Grimm, PC | 1 |
| Nelson, P | 1 |
| Malekzadeh, MH | 4 |
| Fine, RN | 6 |
| Excell, L | 1 |
| Bry, W | 1 |
| Warvariv, V | 1 |
| Bohannon, L | 1 |
| Feduska, N | 1 |
| Straube, B | 1 |
| Collins, G | 1 |
| Levin, B | 1 |
| Belitsky, P | 1 |
| MacDonald, AS | 1 |
| Crocker, J | 1 |
| Hirsch, D | 1 |
| Jindal, K | 1 |
| Lawen, J | 1 |
| Andrien, M | 2 |
| Dupont, E | 2 |
| Goldman, M | 1 |
| Bromberg, JS | 1 |
| Grossman, RA | 1 |
| Tomaszewski, JE | 1 |
| Zmijewski, CM | 1 |
| Perloff, LJ | 1 |
| Asplund, MW | 1 |
| Sack, M | 1 |
| Diliz-Pérez, H | 1 |
| Alvarez, L | 1 |
| Zúñiga, V | 1 |
| Estefan, J | 1 |
| Mares, J | 1 |
| Cerda, L | 1 |
| Luque, E | 1 |
| Carrera, B | 1 |
| Volkow, P | 1 |
| Martínez, R | 1 |
| Oesterwitz, H | 2 |
| Müller, P | 1 |
| Seeger, W | 1 |
| Seibt, F | 1 |
| Horlbeck, R | 2 |
| Hansen, C | 1 |
| Griffin, PJ | 1 |
| Ferguson, CJ | 1 |
| Ross, WB | 1 |
| Salaman, JR | 1 |
| Thayer, C | 1 |
| Bartlett, ST | 1 |
| Ward, RE | 1 |
| Helling, TS | 1 |
| Wood, BC | 1 |
| Nelson, PW | 1 |
| Shelton, LL | 1 |
| Eisenstein, CL | 1 |
| Crouch, TT | 1 |
| Sharma, JN | 1 |
| Mertz, JI | 1 |
| Martin, DC | 3 |
| Tertzakian, G | 1 |
| Ruzics, E | 1 |
| Stiller, C | 1 |
| Keown, P | 1 |
| Awni, WM | 1 |
| Heim-Duthoy, K | 1 |
| Kasiske, BL | 1 |
| Brinker, KR | 1 |
| Dickerman, RM | 1 |
| Gonwa, TA | 3 |
| Hull, AR | 1 |
| Langley, JW | 1 |
| Long, DL | 1 |
| Nesser, DA | 1 |
| Trevino, G | 1 |
| Velez, RL | 1 |
| Vergne-Marini, PJ | 1 |
| Richardson, AJ | 1 |
| Ting, A | 1 |
| Murie, J | 1 |
| Wrenshall, LE | 1 |
| Min, DI | 1 |
| Sibley, RJ | 1 |
| Dunn, DL | 1 |
| Christiaens, R | 1 |
| Hiesse, C | 5 |
| Neyrat, N | 3 |
| Busson, M | 2 |
| Bensadoun, H | 2 |
| Lantz, O | 4 |
| Bellamy, J | 3 |
| Benoit, G | 5 |
| Charpentier, B | 5 |
| Fries, D | 4 |
| Kaufman, DB | 1 |
| Noreen, H | 1 |
| Fryd, DS | 3 |
| Stratta, RJ | 1 |
| D'Alessandro, AM | 1 |
| Armbrust, MJ | 1 |
| Sollinger, HW | 3 |
| Kalayoglu, M | 3 |
| Matas, A | 1 |
| Tellis, V | 1 |
| Quinn, T | 1 |
| Mallis, M | 1 |
| Glicklich, D | 1 |
| Senitzer, DS | 1 |
| Soberman, R | 1 |
| Jaklitsch, MT | 1 |
| Hudson, S | 1 |
| Phillips, MG | 1 |
| Johnson, RW | 2 |
| Dyer, PA | 1 |
| Mallick, NP | 2 |
| Kumar, MS | 2 |
| Samhan, M | 1 |
| John, P | 1 |
| al-Adnani, MS | 1 |
| Abouna, GM | 2 |
| Pearson, RC | 1 |
| Scott, PD | 1 |
| Dyer, P | 1 |
| Donaghue, D | 1 |
| Morris, D | 1 |
| Kootte, AM | 1 |
| van Dorp, WT | 1 |
| van Bockel, JH | 1 |
| van Es, LA | 1 |
| Paul, LC | 1 |
| Bösmüller, C | 2 |
| Spielberger, M | 2 |
| Schmid, T | 2 |
| Posner, MP | 1 |
| Mendez-Picon, G | 1 |
| King, A | 1 |
| Nelson, KP | 1 |
| Spicer, HG | 1 |
| Osakabe, T | 1 |
| Uchida, H | 1 |
| Masaki, Y | 1 |
| Ohkubo, M | 1 |
| Watanabe, K | 1 |
| Büsing, M | 1 |
| Hölzer, H | 1 |
| Schareck, WD | 1 |
| Mellert, J | 1 |
| Greger, B | 1 |
| Hopt, UT | 1 |
| Lauchart, W | 1 |
| Restifo, AC | 1 |
| Jacob, CK | 1 |
| Russ, GR | 1 |
| Frei, D | 1 |
| Hugentobler, M | 1 |
| Probst, W | 1 |
| Uhlschmid, G | 1 |
| Largiadèr, F | 2 |
| Binswanger, U | 1 |
| Oncevski, A | 1 |
| Rostoker, G | 1 |
| Buisson, C | 1 |
| Fruchaud, G | 1 |
| Benmaadi, A | 1 |
| Belghiti, D | 1 |
| Chopin, D | 1 |
| Abbou, C | 1 |
| Bierling, P | 1 |
| Romano, P | 1 |
| Tegzess, AM | 2 |
| van Son, WJ | 2 |
| de Maar, EF | 1 |
| Beelen, JM | 2 |
| Sluiter, WJ | 2 |
| Huisman, RM | 1 |
| Prevost, P | 1 |
| Cantarovich, M | 3 |
| Rieu, P | 2 |
| Rao, KV | 1 |
| Andersen, RC | 1 |
| Forsythe, S | 1 |
| Kamil, E | 2 |
| Salusky, IB | 2 |
| Francis, DM | 2 |
| Millar, RJ | 1 |
| Walker, RG | 2 |
| Clunie, GJ | 1 |
| Toussaint, RM | 1 |
| Callender, CO | 1 |
| Dunston, GM | 1 |
| Flores, J | 1 |
| Walters, CS | 1 |
| John, D | 1 |
| Yeager, C | 1 |
| Bond, O | 1 |
| Thompson, C | 1 |
| Gear, JC | 1 |
| Bartus, S | 2 |
| Bow, L | 1 |
| Hillebrand, G | 1 |
| Castro, LA | 1 |
| Schleibner, S | 1 |
| Land, W | 1 |
| Gurland, HJ | 2 |
| Middleton, D | 1 |
| Gil-Vernet, S | 1 |
| Sabater, R | 1 |
| Franco, E | 1 |
| Torras, J | 1 |
| Larsen, S | 2 |
| Brun, C | 1 |
| Duun, S | 1 |
| Løkkegaard, H | 2 |
| Thomsen, HS | 2 |
| Hall, BM | 4 |
| Hardie, I | 2 |
| Mahoney, J | 1 |
| Thatcher, G | 2 |
| Mathew, T | 2 |
| Thompson, N | 1 |
| Miach, P | 2 |
| Wetzsteon, P | 1 |
| Koyle, M | 1 |
| Glassock, R | 1 |
| Rajfer, J | 2 |
| Ward, H | 1 |
| Friend, PJ | 1 |
| Hale, G | 1 |
| Waldmann, H | 1 |
| Rolles, K | 1 |
| Gore, S | 1 |
| Rovelli, M | 1 |
| Bradley, JW | 1 |
| Cho, SI | 2 |
| Monaco, AP | 2 |
| Szentpetery, S | 1 |
| Thames, M | 1 |
| Hanrahan, J | 1 |
| Morris, J | 1 |
| Lower, RR | 3 |
| Shaffer, D | 1 |
| Hammer, SM | 1 |
| van Valenberg, PL | 1 |
| Hoitsma, AJ | 3 |
| Tiggeler, RG | 1 |
| Berden, JH | 3 |
| van Lier, HJ | 2 |
| Koene, RA | 3 |
| Groenewoud, AF | 1 |
| Feduska, NJ | 3 |
| Melzer, JS | 1 |
| Salvatierra, O | 3 |
| Lewis, RM | 3 |
| Dunn, D | 1 |
| de Mol van Otterloo, JC | 1 |
| Ploeg, RJ | 1 |
| Lilien, MR | 1 |
| Donckerwolcke, RA | 1 |
| van Schilfgaarde, R | 1 |
| Milgrom, M | 1 |
| Kyriakides, GK | 1 |
| Olson, L | 1 |
| Henry, ML | 1 |
| Ludwin, D | 1 |
| Bear, R | 1 |
| Aprile, M | 1 |
| McQuarrie, B | 1 |
| Poole, R | 1 |
| White, N | 1 |
| Rivolta, E | 1 |
| De Vecchi, A | 2 |
| Castelnovo, C | 1 |
| Berardinelli, L | 2 |
| Reyman, TA | 1 |
| Debure, A | 1 |
| Chkoff, N | 1 |
| Chatenoud, L | 1 |
| Lacombe, M | 1 |
| Campos, H | 1 |
| Noël, LH | 1 |
| Goldstein, G | 1 |
| Mahony, J | 1 |
| Thomson, N | 1 |
| Santelli, G | 1 |
| Gardin, JP | 1 |
| Paillard, M | 1 |
| Sagalowsky, AI | 1 |
| Reisman, ME | 1 |
| Dawidson, I | 1 |
| Toto, R | 1 |
| Peters, PC | 1 |
| Helderman, JH | 1 |
| Aigner, F | 1 |
| Smith, AY | 1 |
| Welsh, M | 1 |
| Peters, TG | 1 |
| Stanford, GC | 1 |
| Hidayet, A | 1 |
| Winsett, RP | 1 |
| Britt, LG | 1 |
| Vera, SR | 1 |
| Koyle, MA | 1 |
| Mickey, MR | 1 |
| Glassock, RJ | 1 |
| Ward, HJ | 1 |
| Broyer, M | 1 |
| Gagnadoux, MF | 1 |
| Guest, G | 1 |
| Niaudet, P | 1 |
| Wetzels, JF | 1 |
| Mourad, G | 1 |
| Legendre, C | 1 |
| Argiles, A | 1 |
| Bonardet, A | 1 |
| Mion, C | 1 |
| Hesse, U | 1 |
| Garvin, PJ | 1 |
| Carney, K | 1 |
| Castaneda, M | 1 |
| Codd, JE | 1 |
| Torres, A | 1 |
| Heil, JE | 1 |
| Strand, MH | 1 |
| Ascher, NL | 1 |
| Nghiem, DD | 2 |
| Schulak, JA | 2 |
| Corry, RJ | 2 |
| Serra, JR | 1 |
| Hefty, TR | 1 |
| Wadhwa, N | 1 |
| Penn, I | 6 |
| Munda, R | 1 |
| Fidler, JP | 1 |
| Weiskittel, P | 1 |
| Melzer, J | 1 |
| Amend, WJ | 1 |
| Vincenti, F | 1 |
| Tomlanovich, S | 1 |
| Deierhoi, M | 1 |
| Takahashi, K | 1 |
| Ota, K | 1 |
| Teraoka, S | 1 |
| Fuchinoue, S | 1 |
| Honda, H | 1 |
| Yamashita, N | 1 |
| Okumura, T | 1 |
| Nakazawa, H | 1 |
| Kupin, WL | 2 |
| Norris, C | 1 |
| Florence-Green, D | 1 |
| Dienst, S | 2 |
| Oh, HK | 2 |
| Feldkamp, C | 1 |
| Toussaint, C | 2 |
| Gianello, P | 1 |
| Squifflet, JP | 1 |
| Pirson, Y | 1 |
| Stoffel, M | 1 |
| Dereme, T | 1 |
| Alexandre, GP | 2 |
| Ouziala, M | 1 |
| Shell, T | 1 |
| Gosling, DC | 1 |
| Qerchi della Rovera, G | 1 |
| Crockett, RC | 1 |
| Ahmed, K | 2 |
| Light, JA | 1 |
| Aquino, A | 1 |
| Ali, A | 1 |
| Rodriguez, R | 1 |
| Ali, S | 1 |
| Meijer, S | 1 |
| Slooff, MJ | 1 |
| Samhan, MS | 1 |
| White, AG | 1 |
| Silva, OS | 1 |
| Geoghegan, T | 1 |
| Sharman, VL | 1 |
| Crockett, R | 1 |
| Vegeto, A | 1 |
| Beretta, C | 1 |
| Pasciucco, A | 1 |
| Mihatsch, MJ | 1 |
| Martin, R | 1 |
| Huser, B | 1 |
| Nielsen, SL | 1 |
| Horvath, JS | 2 |
| Duggin, GG | 2 |
| Johnson, JR | 2 |
| Roy, LP | 1 |
| Hurley, B | 1 |
| Harris, JP | 1 |
| Rogers, JR | 1 |
| Stephen, MS | 1 |
| Krueger, TC | 1 |
| Tallent, MB | 2 |
| Richie, RE | 1 |
| Johnson, HK | 1 |
| MacDonell, RC | 1 |
| Turner, B | 1 |
| Braun, W | 1 |
| Mintz, D | 1 |
| Streem, S | 1 |
| Venkatachalam, KK | 1 |
| Schärer, K | 1 |
| Dreikorn, K | 1 |
| Mehls, O | 1 |
| Müller-Wiefel, DE | 1 |
| Horsch, R | 1 |
| Gretz, N | 1 |
| Brittinger, W | 1 |
| Farnsworth, A | 1 |
| May, J | 2 |
| Zanella, A | 1 |
| Egidi, F | 1 |
| Schneck, SA | 1 |
| King, LR | 1 |
| Gerbie, AG | 1 |
| Idriss, FS | 1 |
| Swenson, O | 1 |
| Siegel, A | 1 |
| DelGreco, F | 1 |
| Grayhack, J | 1 |
| Gross, M | 1 |
| Gonzales, E | 1 |
| Stolpe, Y | 1 |
| Küss, R | 1 |
| Legrain, M | 1 |
| Le Gall, JR | 1 |
| Guédon, J | 1 |
| Poisson, J | 1 |
| Coche, E | 1 |
| Sokal, G | 1 |
| Halgrimson, CG | 3 |
| Martineau, G | 1 |
| Schroter, G | 1 |
| Putnam, CW | 3 |
| Cohen, AS | 1 |
| Bricetti, AB | 1 |
| Harrington, JT | 2 |
| Mannick, JA | 3 |
| Hammond, WS | 1 |
| Popovitzer, M | 1 |
| Cascardo, S | 2 |
| Moorhead, JF | 1 |
| Wills, MR | 1 |
| Ahmed, KY | 1 |
| Baillod, RA | 1 |
| Varghese, Z | 1 |
| Tatler, GL | 1 |
| Barnes, RM | 1 |
| Pegrum, GD | 1 |
| Williams, GB | 1 |
| Gordon, EM | 1 |
| de Wardener, HE | 1 |
| Arvanitakis, C | 1 |
| Malek, G | 1 |
| Uehling, D | 1 |
| Morrissey, JF | 1 |
| Moccetti, T | 1 |
| Scheitlin, W | 2 |
| Zaruba, K | 1 |
| Linder, E | 1 |
| Wegmann, W | 1 |
| Owen, K | 2 |
| Loughridge, L | 1 |
| MacGillivray, JB | 1 |
| Swales, JD | 1 |
| Williams, GM | 1 |
| Westerman, MP | 1 |
| Jenkins, JL | 1 |
| Dekker, A | 1 |
| Kreutner, A | 1 |
| Fisher, B | 1 |
| Kiser, WS | 3 |
| Stewart, BH | 4 |
| Hewitt, CB | 3 |
| Gifford, RW | 2 |
| Brettschneider, L | 4 |
| Moon, JB | 2 |
| Fulginiti, VA | 2 |
| Cotton, EK | 1 |
| Porter, KA | 3 |
| Marchioro, TL | 1 |
| McMillan, R | 1 |
| Murray, JE | 3 |
| Wilson, RE | 4 |
| Merrill, JP | 3 |
| Cooper, WC | 1 |
| Birtch, AG | 4 |
| Hager, EB | 2 |
| Dammin, GJ | 1 |
| Harrison, JH | 1 |
| Smith, GV | 1 |
| Kashiwagi, N | 1 |
| Reveillaud, RJ | 1 |
| Leski, M | 1 |
| Mee, AD | 1 |
| Pauly, JL | 1 |
| Han, T | 1 |
| Varkarakis, MJ | 1 |
| Sokal, JE | 1 |
| Sampson, D | 1 |
| Murphy, GP | 1 |
| Moore, TC | 1 |
| Gütgemann, A | 1 |
| Schriefers, KH | 1 |
| Esser, G | 1 |
| Lie, TS | 1 |
| Paquet, KJ | 1 |
| Käufer, C | 1 |
| Grushkin, CM | 3 |
| Wright, HT | 1 |
| Jalota, R | 1 |
| Eichwald, EJ | 1 |
| Urquhart-Hay, D | 1 |
| Morrison, RB | 1 |
| McIlwaine, J | 1 |
| Stephenson, CB | 1 |
| Cable, JV | 1 |
| Lennane, RJ | 1 |
| Fong, R | 1 |
| Powis, SJ | 1 |
| Barnes, AD | 2 |
| Dawson-Edwards, P | 1 |
| Thompson, H | 1 |
| Cerilli, GJ | 1 |
| Nelsen, C | 1 |
| Dorfmann, L | 1 |
| Silcott, GR | 1 |
| Barbour, BH | 1 |
| Bischel, MD | 1 |
| Berne, TV | 1 |
| Parsons, V | 1 |
| Snowdon, SA | 1 |
| Manuel, L | 1 |
| Briggs, JD | 1 |
| Calman, KC | 1 |
| Quin, RO | 1 |
| Wood, RF | 1 |
| Paton, A | 1 |
| Macpherson, SG | 1 |
| Farrow, GA | 1 |
| Wilson, DR | 1 |
| Fenton, SS | 1 |
| Hayman, WP | 1 |
| Halbfass, HJ | 1 |
| Staib, I | 1 |
| Heinze, V | 1 |
| Jontofsohn, R | 1 |
| Junkers, K | 1 |
| Corman, J | 1 |
| Husberg, B | 1 |
| Gustafsson, A | 1 |
| Geis, P | 1 |
| Haines, RF | 1 |
| Freier, DT | 1 |
| Gikas, PW | 1 |
| Johnson, AG | 1 |
| Thompson, NW | 1 |
| Korsch, BM | 2 |
| Brennan, LP | 2 |
| Edelbrock, HH | 2 |
| Stiles, QR | 1 |
| Riddell, HI | 1 |
| Weitzman, JJ | 1 |
| Mickelson, JC | 1 |
| Tucker, BL | 1 |
| Ghose, MK | 1 |
| Kest, LM | 1 |
| Cohen, SM | 1 |
| Roza, O | 1 |
| Berman, LB | 1 |
| Lidsky, I | 1 |
| Teitelbaum, S | 1 |
| Galvin, JB | 1 |
| Laplate, L | 1 |
| Briggs, WA | 1 |
| Lazarus, JM | 1 |
| Hampers, CL | 1 |
| Cotton, JR | 1 |
| Searls, AG | 1 |
| Remmers, AR | 1 |
| Lindley, JD | 1 |
| Beathard, GA | 1 |
| Cottom, DL | 1 |
| Fish, JC | 1 |
| Townsend, CM | 1 |
| Ritzmann, SE | 1 |
| Horbach, J | 1 |
| van Liebergen, F | 1 |
| Mastboom, J | 1 |
| Wijdeveld, P | 1 |
| Hricko, GM | 1 |
| Bennett, AH | 1 |
| Marshall, DF | 1 |
| Drewry, J | 1 |
| Ray, FS | 1 |
| Storm, B | 2 |
| Tomilina, NA | 1 |
| L'vitsina, GM | 1 |
| McCullough, DL | 1 |
| Gittes, RF | 1 |
| Mahon, FB | 1 |
| Malek, GH | 1 |
| Uehling, DT | 1 |
| Gonda, A | 1 |
| Gorman, P | 1 |
| Vineyard, GC | 1 |
| Fadem, SZ | 1 |
| Dmochowski, J | 1 |
| Vertuno, LL | 1 |
| Preuss, HG | 1 |
| Argy, WP | 1 |
| Schreiner, GE | 1 |
| Myers, BD | 1 |
| Kessler, E | 1 |
| Levi, J | 1 |
| Pick, A | 1 |
| Rosenfeld, JB | 1 |
| Tikvah, P | 1 |
| Marshall, V | 1 |
| Nolan, GH | 1 |
| Sweet, RL | 1 |
| Laros, RK | 1 |
| Roure, CA | 1 |
| Coles, GA | 1 |
| White, HJ | 1 |
| Silverman, NA | 1 |
| Gunnells, JC | 2 |
| Stickle, DL | 1 |
| Weeke, E | 1 |
| Ljunghall, S | 1 |
| Fjellström, KE | 1 |
| Wibell, L | 1 |
| Swanson, MK | 1 |
| McGregor, WR | 1 |
| Rodgers, RE | 1 |
| Fox, PS | 1 |
| Pierce, JC | 2 |
| Hall, CL | 1 |
| Wickramasinghe, SN | 1 |
| Dodsworth, H | 1 |
| Rault, RM | 1 |
| Hulme, B | 2 |
| Firlit, CF | 1 |
| Davis, RC | 2 |
| Nabseth, DC | 2 |
| Olsson, CA | 2 |
| Idelson, BA | 2 |
| Schmitt, GW | 2 |
| Stenzel, KH | 1 |
| Susin, M | 1 |
| Rubin, AL | 1 |
| Whitsell, JC | 1 |
| Thomas, F | 1 |
| Wolf, JS | 2 |
| Thomas, J | 1 |
| Cleveland, RJ | 1 |
| Kelly, WD | 1 |
| Lillehei, RC | 1 |
| Aust, JB | 1 |
| Varco, RL | 1 |
| Leonard, AS | 1 |
| Griffin, WO | 1 |
| Markland, C | 1 |
| Herdman, RC | 1 |
| Vernier, RL | 1 |
| Michael, AF | 1 |
| Levitt, J | 1 |
| Van Geertruyden, J | 1 |
| Zenker, R | 1 |
| Erpenbeck, R | 1 |
| Besirsky, HW | 1 |
| Jabour, A | 1 |
| Edel, H | 1 |
| Müller, R | 1 |
| Altmeyer, B | 1 |
| Dobbelstein, H | 1 |
| Blanchard, H | 1 |
| Martin, AJ | 1 |
| Goodwin, WE | 2 |
| Kaufman, JJ | 2 |
| Mims, MM | 1 |
| Goldman, R | 2 |
| Rubini, M | 1 |
| Gonick, H | 1 |
| Moore, FD | 1 |
| Burch, GE | 1 |
| Harken, DE | 1 |
| Swan, HJ | 1 |
| Lillihei, CW | 1 |
| Stewart, JH | 1 |
| Johnson, J | 1 |
| Tiller, D | 1 |
| George, CR | 1 |
| Rogers, JH | 1 |
| Storey, BG | 1 |
| Mani, MK | 1 |
| Gibson, GR | 1 |
| Sharp, A | 1 |
| Wyatt, KM | 1 |
| Sands, JR | 1 |
| Loewenthal, J | 1 |
| Ackman, D | 1 |
| Doak, PB | 2 |
| Dalton, NT | 1 |
| Meredith, J | 1 |
| Montgomerie, JZ | 1 |
| North, JD | 1 |
| Idezuki, Y | 1 |
| Stiles, Q | 1 |
| Riddell, H | 1 |
| Lieberman, E | 1 |
| Stevens, LE | 1 |
| Reemtsma, K | 1 |
| Latimer, RG | 1 |
| Maxwell, JG | 1 |
| Weaver, DH | 1 |
| Ward, JS | 1 |
| Eslami, H | 1 |
| Parsonnet, V | 1 |
| LaPlante, MP | 1 |
| Gonick, HC | 1 |
| Iarmolinskiĭ, IS | 1 |
| Gorianov, VA | 1 |
| Cooperband, SR | 1 |
| Glasgow, AH | 1 |
| Williams, LF | 1 |
| Cavallo, T | 1 |
| Patel, R | 1 |
| Busch, G | 1 |
| Reeves, DS | 1 |
| Leb, DE | 1 |
| Weisskopf, B | 1 |
| Kanovitz, BS | 1 |
| Scotti-Foglieni, C | 1 |
| Salvadeo, A | 1 |
| Cortinovis, R | 1 |
| Colombo, P | 1 |
| Donati, GS | 1 |
| Uggeri, F | 1 |
| Magni, M | 1 |
| Pedroni, G | 1 |
| Mebel, M | 1 |
| Amos, DB | 1 |
| Anderson, EE | 1 |
| Glenn, JF | 1 |
| Lancaster, SL | 1 |
| MacQueen, JM | 1 |
| Robinson, RR | 1 |
| Seigler, HF | 1 |
| Stickel, DL | 1 |
| Ward, FE | 1 |
| Meere, C | 1 |
| Grondin, CM | 1 |
| Castonguay, Y | 1 |
| Lepage, G | 1 |
| Grondin, P | 1 |
| Levitt, SH | 1 |
| Royster, RL | 1 |
| O'Foughludha, FT | 1 |
| King, ER | 1 |
| DeGiorgi, LS | 1 |
| Hamburger, J | 1 |
| Mowbray, JF | 1 |
| Cohen, SL | 1 |
| Kenyon, JR | 1 |
| Percival, A | 1 |
| Peart, WS | 1 |
| Hewitt CB KISER, WS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early vs Late Urinary Catheter Removal After Renal Transplantation Randomised Clinical Trial[NCT04815954] | 450 participants (Anticipated) | Interventional | 2019-03-26 | Recruiting | |||
| A Pilot Study to Evaluate the Safety and Efficacy of Mycophenolate Sodium (Myfortic®) in Combination With Sirolimus (Rapamune®) in Stable Renal Allograft Recipients[NCT00713284] | Phase 4 | 29 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| Pilot Trial for Implementation of a MPA PK Monitoring Strategy[NCT00187915] | 24 participants (Actual) | Interventional | 2003-07-31 | Completed | |||
| A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients[NCT01163799] | Phase 1 | 9 participants (Actual) | Interventional | 2010-07-31 | Terminated (stopped due to Noted increased risks, greater than expected for standard of care therapy.) | ||
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA, Versus Standard Dose Tacrolimus, ECMPA Plus Corticosteroids in Patients Undergoing Liver Transplant[NCT02123108] | Phase 4 | 59 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| The Highly Sensitized Patients: Effects of Rituximab and Mycophenolate Mofetil (MMF) On Anti-Human Leukocyte Antigen (HLA) Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.[NCT00446251] | Phase 2 | 14 participants (Actual) | Interventional | 2006-12-31 | Completed | ||
| The Highly Sensitized Patients: Effects of Mycophenolate Mofetil (MMF) On Anti-Human Leukocyte Antigen (HLA) Antibody Levels In Patients Awaiting Cadaveric Renal Transplant[NCT00446459] | Phase 2 | 45 participants (Actual) | Interventional | 2006-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Renal allograft function will be assessed based on serum creatinine (NCT00713284)
Timeframe: six months
| Intervention | mg/dL (Mean) | |
|---|---|---|
| Creatinine (Baseline) | Creatinine (6 months) | |
| Sirolimus Conversion | 1.34 | 1.38 |
(NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 3 |
| Tacrolimus Group | 4 |
(NCT02123108)
Timeframe: 12 months post liver transplantation
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 0 |
| Tacrolimus Group | 0 |
(NCT02123108)
Timeframe: 12 months post transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 2 |
| Tacrolimus Group | 5 |
Number of participants who experienced dialysis independence or improvement based upon kidney function labs as a measure of renal recovery/ function following OLT in patients after undergoing orthotopic liver transplant (NCT02123108)
Timeframe: 12 months post-transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
Participants at risk minus incidence of death within the first year post-transplant (NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
(NCT00446251)
Timeframe: Month 12 from start of study
| Intervention | Participants (Number) |
|---|---|
| Rituximab Infusion and Mycophenolate Mofetil Group | 6 |
the number of subjects who experience a decrease in their Panel of Reactive Antibodies (PRA) at 6 months and 12 months post Rituximab infusion (NCT00446251)
Timeframe: Month 6 from start of study
| Intervention | Participants (Number) |
|---|---|
| Rituximab Infusion and Mycophenolate Mofetil Group | 6 |
(NCT00446251)
Timeframe: Month 12 from start of study
| Intervention | Participants (Number) |
|---|---|
| Rituximab Infusion and Mycophenolate Mofetil Group | 0 |
The number of kidney transplants up to month 12. Subjects who's PRA decreased by 10% at month 8 and who went on to the Mycophenolate mofetil + Rituximab study were followed to month 8. Those subjects who stayed on the Mycophenolate mon-therapy study were observed for infection over 12 months or until they seperated from the study. (NCT00446459)
Timeframe: Enrollment to month 8 or month 12 post enrollment.
| Intervention | Participants (Number) |
|---|---|
| Mycophenolate Mofetil (MMF) Single Arm Study | 3 |
The number of subjects with adverse hematologic effects with MMF while on-study. Subjects who's PRA decreased by 10% at month 8 and who went on to the Mycophenolate mofetil + Rituximab study were followed to month 8. Those subjects who stayed on the Mycophenolate mon-therapy study were observed for hematologic effects up to 12 months. (NCT00446459)
Timeframe: Enrollment to month 12.
| Intervention | Participant (Number) |
|---|---|
| Mycophenolate Mofetil (MMF) Single Arm Study | 0 |
(NCT00446459)
Timeframe: Enrollment to month 8
| Intervention | Participant (Number) |
|---|---|
| Mycophenolate Mofetil (MMF) Single Arm Study | 9 |
The number of infections while on-study up to month 12. Subjects who's PRA decreased by 10% at month 8 and who went on to the Mycophenolate mofetil + Rituximab study were followed to month 8. Those subjects who stayed on the Mycophenolate mon-therapy study were observed for infection over 12 months or until they seperated from the study. (NCT00446459)
Timeframe: From enrollment to month 12.
| Intervention | Participants (Number) |
|---|---|
| Mycophenolate Mofetil (MMF) Single Arm Study | 4 |
The number negative crossmatch transplants up to month 12. Positivie crossmatch transplant carries a higher risk for rejection. Subjects who's PRA decreased by 10% at month 8 and who went on to the Mycophenolate mofetil + Rituximab study were followed to month 8. Those subjects who stayed on the Mycophenolate mon-therapy study were observed for negative crossmatch transplants to 12 months. (NCT00446459)
Timeframe: Number of Transplants with a Negative Crossmatch.
| Intervention | Participant (Number) |
|---|---|
| Mycophenolate Mofetil (MMF) Single Arm Study | 0 |
11 reviews available for azathioprine and Cadaver
| Article | Year |
|---|---|
Annual trends and triple therapy--1991-2000.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combi | 2001 |
Clinical renal transplantation.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Blood Transfusion; Cadaver; Cyclosporin | 1983 |
Uses of antilymphocyte globulin in renal transplantation.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Azathioprine; Blood Transfusion; Cadaver; Graft Rejectio | 1983 |
Steps in immunosuppression for renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Blood Transfusion; Cadaver; Clinical Trials as Topic; Cyclospori | 1983 |
Long-term safety profile of sandimmune in renal transplantation.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporine; Graft Rejection; Graft Survival; Humans; Hypertensi | 1992 |
Sequential therapy in pediatric cadaveric renal transplantation: a critical analysis.
Topics: Adult; Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Cyclosporine; Graft Survival | 1992 |
Organ transplantation. The present position and future prospects of organ transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Dactinomycin; Female; Heart Transplantation; Histocompa | 1969 |
Current status of renal transplantation in small children.
Topics: Angiography; Anti-Bacterial Agents; Azathioprine; Cadaver; Child; Child, Preschool; Diet; Drainage; | 1974 |
Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Cobalt Radioisotopes; Cytot | 1974 |
Clinical renal transplantation.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclophosphamide; Diabetes Com | 1974 |
[Present status and future of pancreatic transplantation].
Topics: Adult; Amylases; Animals; Azathioprine; Blood Glucose; Cadaver; Diabetes Mellitus, Type 1; Dogs; Duo | 1969 |
119 trials available for azathioprine and Cadaver
| Article | Year |
|---|---|
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty.
Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Black People; Cadaver; Coronary Disease; Cyclos | 2003 |
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; | 2003 |
Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
Topics: Absorptiometry, Photon; Azathioprine; Bone and Bones; Bone Density; Cadaver; Cyclosporine; Drug Ther | 2003 |
Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy | 1992 |
Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Europe; Graft Survival; Humans; Kidne | 1982 |
Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Follow-Up St | 1983 |
A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Double-Blind Method; Female; Graft Rejection; Gr | 1983 |
Steps in immunosuppression for renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Blood Transfusion; Cadaver; Clinical Trials as Topic; Cyclospori | 1983 |
Cadaveric renal transplantation under cyclosporine-steroid therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Clinical Trials as Topic; Creatinine; Cyclosporins; | 1983 |
Cyclosporin A used alone or in combination with low-dose steroids in cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Female; Humans; Immunosuppression Th | 1983 |
Cyclosporine: five years' experience in cadaveric renal transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Child; Child, Preschool; Clinical Trials as Topic; C | 1984 |
A prospective randomized trial of low-dose versus high-dose steroids in cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Female; Glucocorticoids; Graft Rejection; Humans; Kidney Transplantati | 1984 |
[Clinical results of immunosuppression with cyclosporin A in cadaveric kidney transplantation].
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Clinical Trials as Topic; Cyclosporins; Female; Gra | 1984 |
Experience with cyclosporine and steroids in clinical renal transplantation.
Topics: Actuarial Analysis; Adult; Azathioprine; Cadaver; Chemical and Drug Induced Liver Injury; Clinical T | 1984 |
[Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Drug Therapy, Combination; Gr | 1984 |
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Creatinine; Drug Therapy, Combin | 1983 |
Antithymocyte globulin in cadaver kidney transplantation: a randomized trial based on T-cell monitoring.
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Female; Graft Survival; Hor | 1981 |
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.
Topics: Actuarial Analysis; Adult; Azathioprine; Cadaver; Drug Therapy, Combination; Follow-Up Studies; Graf | 1994 |
Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Drug Monitoring; F | 1995 |
Long-term results with elective cyclosporine withdrawal at three months after renal transplantation--appropriate for living-related transplants.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Cyclosporine; Dose-Response Relationship, Drug; Fam | 1994 |
Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
Topics: Azathioprine; Cadaver; Drug Therapy, Combination; Female; Follow-Up Studies; Histocompatibility Test | 1995 |
Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
Topics: Antihypertensive Agents; Azathioprine; Blood Pressure; Cadaver; Creatinine; Cyclosporine; Drug Thera | 1994 |
Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Histocompa | 1994 |
A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Topics: Actuarial Analysis; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclospori | 1993 |
Cyclosporine versus azathioprine: a 5-year followup of 200 consecutive cadaver renal transplant recipients.
Topics: Azathioprine; Biopsy; Cadaver; Cyclosporine; Follow-Up Studies; Graft Survival; Humans; Immunosuppre | 1994 |
Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Cadaver; Creatinine; Dru | 1993 |
Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation?
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Follow-Up Studies; Graft Survival; Humans | 1993 |
Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Aus
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Azathioprine; Blood Transfusion; Cadaver; Cyclosporine; | 1993 |
Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function.
Topics: Actuarial Analysis; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Costs and Cost Analysis; Cyc | 1993 |
Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine.
Topics: Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; H | 1993 |
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Topics: Adult; Aged; Azathioprine; Cadaver; Double-Blind Method; Female; Graft Rejection; Humans; Immunosupp | 1996 |
Current advantage of FK 506 in cadaveric kidney transplantation.
Topics: Antibodies, Monoclonal; Azathioprine; Cadaver; Cyclosporine; Cytomegalovirus Infections; Drug Therap | 1996 |
A cost-effectiveness analysis of OKT3 induction therapy in cadaveric kidney transplantation.
Topics: Anti-Infective Agents; Azathioprine; Cadaver; Cost-Benefit Analysis; Cyclosporine; Drug Costs; Graft | 1996 |
Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Topics: Aged; Azathioprine; Cadaver; Calcium Channel Blockers; Costs and Cost Analysis; Cyclosporine; Drug T | 1996 |
Hyperamylasemia in kidney transplant recipients.
Topics: Alanine Transaminase; Amylases; Aspartate Aminotransferases; Azathioprine; Cadaver; Cyclosporine; Dr | 1996 |
Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Drug Combinations; Female; Follow-Up S | 1996 |
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
Topics: Adult; Aged; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Gra | 1996 |
[The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers].
Topics: Adult; Anticholesteremic Agents; Azathioprine; Cadaver; Cholesterol; Cholesterol, LDL; Creatinine; C | 1997 |
The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Topics: Acute Disease; Azathioprine; Cadaver; Cost-Benefit Analysis; Graft Rejection; Graft Survival; Humans | 1997 |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Dopamine; Drug Administration Schedule; Furosemide; Humans; Immunosupp | 1998 |
A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Topics: Adult; Azathioprine; Black People; Cadaver; Cyclosporine; Female; Graft Rejection; Graft Survival; H | 1999 |
Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
Topics: Azathioprine; Cadaver; Double-Blind Method; Follow-Up Studies; Graft Rejection; Graft Survival; Huma | 1999 |
A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Drug Administration Schedule; Drug The | 1997 |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Human | 2000 |
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Diabetes Mellitus; Drug Therapy, Combination; Female; G | 2000 |
Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors.
Topics: Adult; Age Factors; Azathioprine; Blood Transfusion; Cadaver; Confidence Intervals; Creatinine; Cycl | 2000 |
Randomised open clinical trial of conversion from mycophenolate mofetil to azathioprine in cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rej | 2000 |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis.
Topics: Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studi | 2000 |
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Topics: Adult; Azathioprine; Cadaver; Cause of Death; Cyclosporine; Drug Therapy, Combination; Female; Follo | 2000 |
Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Cyclosporine; Drug Therapy, C | 2000 |
The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Reject | 2000 |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Topics: Administration, Oral; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Black People; Cadaver; | 2001 |
Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Creatine; Cyclosporine; Drug Therapy, Combination; G | 2001 |
Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Topics: Adult; Aged; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cadaver; Drug Therapy, Combination; | 2002 |
Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Cholesterol; Creatinine; Drug Therapy, Combination; | 2002 |
A controlled trial of antihuman lymphocyte globulin (Behring) in cadaveric renal transplantation: improvement in graft and patient survival at one year using a high-dose regimen.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Dose-Response Relationship, D | 1977 |
Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Female; Graft Rejectio | 1979 |
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Creatinine; Graft Rejec | 1976 |
Effect of alternate-day steroids on renal transplant function. A controlled study.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Drug Administration Schedule; Graft Rejection; Huma | 1976 |
A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graf | 1992 |
Cyclosporine immunosuppression in non-heart-beating cadaver donors.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Graft Rejection; Humans; I | 1992 |
Chronic rejection of renal allografts with four immunosuppressive regimens.
Topics: Azathioprine; Biopsy; Cadaver; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up S | 1992 |
Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine.
Topics: Adult; Analysis of Variance; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; | 1992 |
Cadaveric renal transplant without prophylactic prednisone therapy.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Diabetes Complications; Graft Survival; H | 1991 |
Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Graft Rejection; Graft Survival; Humans; | 1991 |
Renal transplantation despite a positive antiglobulin crossmatch with and without prophylactic OKT3.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Cadaver; Coombs Test; Female; Graft Rejection; Histocom | 1991 |
Renal transplantation despite a positive antiglobulin crossmatch with and without prophylactic OKT3.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Cadaver; Coombs Test; Female; Graft Rejection; Histocom | 1991 |
Renal transplantation despite a positive antiglobulin crossmatch with and without prophylactic OKT3.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Cadaver; Coombs Test; Female; Graft Rejection; Histocom | 1991 |
Renal transplantation despite a positive antiglobulin crossmatch with and without prophylactic OKT3.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Cadaver; Coombs Test; Female; Graft Rejection; Histocom | 1991 |
Triple drug therapy in haploidentical living related and cadaveric kidney transplantation.
Topics: Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Family; Follow-Up Studies; Graft Rej | 1991 |
Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Topics: Azathioprine; Bone Marrow Transplantation; Cadaver; Cyclosporins; Family; Follow-Up Studies; Graft S | 1990 |
Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
Topics: Antibodies, Monoclonal; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Follow-Up St | 1990 |
A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Fem | 1990 |
Increased septic complications with three-drug sequential immunosuppression for cadaver renal transplants.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Bacterial Infections; Cadaver; Cyclosporins; Female; Graf | 1990 |
A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination | 1990 |
Early graft function in primary and regraft recipients of paired cadaveric kidneys.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Follow-Up | 1989 |
Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Fem | 1989 |
Cadaver renal transplantation without maintenance steroids.
Topics: Azathioprine; Blood Transfusion; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Administratio | 1989 |
Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Creatinine; Cyclosporins; Drug Administration Sched | 1989 |
Cyclosporine (Cy) monotherapy after cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Female; HL | 1989 |
Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Creatinine; Cyclosporins; Dru | 1989 |
Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Topics: Animals; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Dogs; Drug Therapy, Combinat | 1989 |
Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Administra | 1989 |
A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Fem | 1989 |
Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Creatinine; Cyclosporins; Drug A | 1989 |
Is long-term triple drug therapy required for maintaining kidney allograft tolerance? Effect of azathioprine withdrawal at three months posttransplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Drug Therapy, Combination; Gr | 1989 |
Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Topics: Azathioprine; Blood Pressure; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combina | 1989 |
The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Cycl | 1989 |
Factors influencing the improvement in cadaveric renal transplant survival in pediatric recipients.
Topics: Adolescent; Age Factors; Azathioprine; Cadaver; Child; Clinical Trials as Topic; Cyclosporins; Drug | 1989 |
Successful cadaveric renal transplantation in infants and young children.
Topics: Azathioprine; Cadaver; Child; Child, Preschool; Clinical Trials as Topic; Creatinine; Cyclosporins; | 1989 |
Serum beta 2 microglobulin monitoring in cadaver kidney transplant recipients with oliguric renal failure.
Topics: Anuria; Azathioprine; beta 2-Microglobulin; Biomarkers; Cadaver; Clinical Trials as Topic; Cyclospor | 1989 |
Transplantation of cadaver kidneys from pediatric and older donors.
Topics: Adult; Age Factors; Azathioprine; beta 2-Microglobulin; Biomarkers; Cadaver; Child, Preschool; Clini | 1989 |
A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibody Formation; Azathioprine; Cadaver; Clinical | 1985 |
A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
Topics: Acidosis, Renal Tubular; Adolescent; Adult; Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver | 1986 |
[Cyclosporin A in cadaveric kidney transplantation. A randomized study].
Topics: Azathioprine; Cadaver; Child; Clinical Trials as Topic; Cyclosporins; Female; Graft Rejection; Human | 1988 |
Australian multicentre trial in cadaver renal transplantation comparison of short- and long-term cyclosporine A therapy with conventional therapy.
Topics: Australia; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Administration Schedu | 1987 |
Cyclosporine versus azathioprine in high risk cadaver kidney transplant recipients: a prospective randomized study.
Topics: Azathioprine; Cadaver; Cyclosporins; Humans; Kidney Transplantation; Prospective Studies; Risk Facto | 1987 |
Cyclosporine in cadaveric renal transplantation: a comparison of two immunosuppressive protocols.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Creatinine; Cyclosporins; Graft Rejection; Humans; | 1987 |
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; B-Lymphocytes; Cadaver; Cyclosporins; Humans; Kidney Tr | 1987 |
A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Follow-Up | 1987 |
Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclo | 1987 |
Cardiac transplantation in the sixth decade of life.
Topics: Adult; Age Factors; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Blood Grouping and C | 1987 |
Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation.
Topics: Acute Kidney Injury; Azathioprine; Cadaver; Cyclosporins; Glucose; Humans; Intraoperative Care; Kidn | 1987 |
Important role for mannitol in the prevention of acute renal failure after cadaveric kidney transplantation.
Topics: Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Humans; Kidney Transplantation; Manni | 1987 |
A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
Topics: Actuarial Analysis; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, | 1988 |
A comparison of two cyclosporine protocols at the University of Minnesota.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft S | 1988 |
One-month prophylactic use of OKT3 in cadaver kidney transplant recipients.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cadaver; Drug Therapy, Combinatio | 1988 |
Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Drug | 1988 |
Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporins; Diuresis; Dose-Response Relationship, Drug; Drug Th | 1988 |
Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
Topics: Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Graft Rejection; Humans; Immunosu | 1988 |
Triple therapy including cyclosporine A versus conventional regimen--a randomized prospective study in pediatric kidney transplantation.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschool; Clinical Trials as | 1987 |
Sequential conventional and cyclosporine therapy in cadaver renal transplantation--a prospective randomized trial.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclosporins; Drug Administration Schedule; | 1987 |
The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Topics: Actuarial Analysis; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Dr | 1986 |
Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Follow-Up Studies; Graft Survi | 1987 |
Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug The | 1987 |
Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Fem | 1987 |
Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cadaver; Child; Cyclosporins; Female | 1985 |
Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials | 1985 |
Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
Topics: Acute Kidney Injury; Antilymphocyte Serum; Azathioprine; Cadaver; Clinical Trials as Topic; Cyclospo | 1985 |
Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cost-Benefit Analysis; Creatinine; Cyclospor | 1985 |
Antithymocyte globulin in renal transplant krecipients. A clinical trial.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Basement Membrane; Blood Proteins; Cadaver; Cytotoxicit | 1973 |
Co-trimoxazole and azathioprine: a safe combination.
Topics: Administration, Oral; Azathioprine; Cadaver; Clinical Trials as Topic; Drug Therapy, Combination; Hu | 1974 |
297 other studies available for azathioprine and Cadaver
| Article | Year |
|---|---|
Electrolyte free water clearance could be an early sign of renal dysfunction in renal transplant patients.
Topics: Adult; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drinking; Electrolytes; Female; Humans; Immu | 2009 |
Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.
Topics: Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Calcineurin Inhibitors; Creatinine; Delaye | 2012 |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Heart Arrest; Humans; | 2002 |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Weight; Cadaver; California; Child; Cyclosporin | 2002 |
Results of renal transplantation over 20 years after surgery, using azathioprine and low-dose prednisolone as the sole immunosuppression.
Topics: Adult; Azathioprine; Cadaver; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; | 2003 |
Impact of delayed graft function on cadaveric kidney transplant outcome.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Drug Therapy, Combination; Follow-Up Studies; Graft Rej | 2003 |
Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation.
Topics: Adolescent; Adult; Analysis of Variance; Azathioprine; Cadaver; Child; Child, Preschool; Female; Gra | 2003 |
A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.
Topics: Adolescent; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; | 2003 |
RENAL HOMOTRANSPLANTATION IN 24 PATIENTS.
Topics: Anemia; Anemia, Macrocytic; Antineoplastic Agents; Azathioprine; Blood Group Incompatibility; Cadave | 1965 |
CADAVER RENAL HOMOTRANSPLANTS: INITIAL EXPERIENCES.
Topics: Azathioprine; Cadaver; Dactinomycin; Enzymes; Histoplasmosis; Humans; Imidazoles; Immunosuppressive | 1964 |
STUDIES OF RENAL HOMOTRANSPLANTATION IN MAN.
Topics: Azathioprine; Blood Group Antigens; Cadaver; Immunosuppressive Agents; Kidney; L-Lactate Dehydrogena | 1964 |
CLINICAL EXPERIENCE WITH RENAL TRANSPLANTATION.
Topics: Azathioprine; Cadaver; Dactinomycin; Drug Therapy; Hemorrhage; Humans; Hypertension; Immunosuppressi | 1965 |
Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients.
Topics: Azathioprine; Cadaver; Creatinine; Drug Therapy, Combination; Follow-Up Studies; Histocompatibility | 1992 |
Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graf | 2004 |
The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation.
Topics: ABO Blood-Group System; Adult; Azathioprine; Body Weight; Cadaver; Cytomegalovirus; Cytomegalovirus | 2005 |
Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers.
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Cadaver; Cohort Studies; Female; Follow-Up Studi | 2005 |
Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Cytomegalovirus Infections; Drug Therapy, Combinatio | 2005 |
Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
Topics: Acute Disease; Antibody Formation; Antilymphocyte Serum; Azathioprine; Cadaver; Down-Regulation; Fem | 2005 |
Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Hepat | 2006 |
Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.
Topics: Adult; Azathioprine; Cadaver; Case-Control Studies; Cyclosporine; Female; Follow-Up Studies; Graft R | 2007 |
Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts.
Topics: Animals; Azathioprine; Cadaver; Chromatography, High Pressure Liquid; Cyclosporins; Cytotoxicity, Im | 1982 |
Suppressor factor in plasma of aminophylline treated renal transplanted patients.
Topics: Aminophylline; Azathioprine; Cadaver; Graft Rejection; Graft vs Host Reaction; Humans; Kidney Transp | 1983 |
Beneficial effect of pre-transplant splenectomy for leukopenia in primary cadaver kidney transplants.
Topics: Azathioprine; Cadaver; Graft Survival; Humans; Kidney Transplantation; Leukopenia; Splenectomy | 1983 |
Acute rejection episodes after renal transplantation in children.
Topics: Acute Disease; Adolescent; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschool; Dru | 1983 |
Cadaver kidney allograft survival in a high-risk black population utilizing antilymphoblast globulin and low steroid therapy.
Topics: Antilymphocyte Serum; Azathioprine; Black People; Cadaver; Graft Survival; Humans; Immunosuppression | 1983 |
Second cadaver kidney transplants: improved graft survival in secondary kidney transplants using cyclosporin A.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Cyclosporins; Follow-Up Studies; Graft Survival; Hu | 1984 |
Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Graft Rejection; HLA Antigens; Humans; Immunosuppressio | 1984 |
Cadaveric kidney transplantation in diabetics after total lymphoid irradiation (TLI).
Topics: Adult; Azathioprine; Blood Transfusion; Cadaver; Diabetic Nephropathies; Follow-Up Studies; Graft Re | 1984 |
Minnesota experience with 81 pancreas transplants since 1978.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Blood Glucose; Cadaver; Cyclosporins; Diabetes Mellitus, | 1984 |
Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Female; Graft Rej | 1984 |
Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Drug Therapy, Combination; Female; Graft Surviva | 1982 |
Lymphokine responses in renal transplant recipients.
Topics: Azathioprine; Cadaver; Concanavalin A; Cyclosporins; Graft Rejection; Humans; Immunosuppressive Agen | 1982 |
Advantage of long-term alternate day steroid therapy in renal transplantation: a controlled study.
Topics: Adult; Azathioprine; Bacterial Infections; Cadaver; Graft Rejection; Humans; Kidney Failure, Chronic | 1980 |
Advantages of low dose steroid from the day after renal transplantation.
Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Cadaver; Child; Diabetes Mellitus; Gastrointe | 1980 |
Azathioprine-induced leukopenia--clinical significance in renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Female; Humans; Kidney Transplantation; Leukocyte Count; Leukopenia; M | 1980 |
[Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Graft Survival; Humans; Immunosuppressive Agents; Kidne | 1980 |
Granulocyte function in recipients of renal transplant from live related donors and from cadavers.
Topics: Azathioprine; Blood Bactericidal Activity; Cadaver; Chemotaxis, Leukocyte; Graft Rejection; Granuloc | 1980 |
Comparison of standard immunosuppression with adjuvant antilymphoblast globulin in primary cadaver kidney transplant survival.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Graft Rejection; Graft Survival; Humans; Immunosuppress | 1982 |
Improved results in high risk cadaveric kidney transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Graft Survival; Humans; Immune Tolerance; Immunosuppres | 1980 |
Pediatric renal transplantation in a single center from Brazil.
Topics: Adolescent; Azathioprine; Brazil; Cadaver; Child; Cyclosporine; Family; Graft Rejection; Graft Survi | 1995 |
Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Female; Graft Survival; Humans; Immunosuppression Therap | 1995 |
Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome.
Topics: Azathioprine; Blood Transfusion; Cadaver; Complement System Proteins; Cyclosporine; Cytotoxicity, Im | 1995 |
Transplantation in Singapore.
Topics: Actuarial Analysis; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Survival; | 1995 |
Early prognosis of 263 renal allografts harvested from non-heart-beating cadavers using an in situ cooling technique.
Topics: Adult; Age Factors; Azathioprine; Cadaver; Cyclosporine; Humans; Ischemia; Kidney; Kidney Transplant | 1995 |
Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Co | 1995 |
Cadaveric renal transplantation with cyclosporine monotherapy.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft S | 1994 |
Causes of death after renal transplantation: a long-term follow-up study.
Topics: Azathioprine; Cadaver; Cause of Death; Cyclosporine; Family; Follow-Up Studies; Humans; Immunosuppre | 1994 |
Influence of immunosuppression on cadaver kidney graft survival.
Topics: Azathioprine; Cadaver; Clinical Protocols; Cyclosporine; Female; Graft Survival; Humans; Immunosuppr | 1994 |
[The calcium-binding properties of the plasma proteins from patients with aseptic necrosis of bone following a cadaveric kidney allograft].
Topics: Adolescent; Adult; Azathioprine; Cadaver; Calcium-Binding Proteins; Femur Head Necrosis; Follow-Up S | 1993 |
Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.
Topics: Adolescent; Adult; Aged; Azathioprine; Black People; Cadaver; Canada; Child; Child, Preschool; Cyclo | 1994 |
Study of the effect of HLA class II antigens (serotyping and mixed lymphocyte reaction) on kidney graft outcome.
Topics: Azathioprine; Cadaver; Cyclosporine; Family; Genotype; Graft Survival; Histocompatibility Testing; H | 1993 |
Klatskin's tumour 10 years after successful cadaveric renal transplantation.
Topics: Adenoma, Bile Duct; Azathioprine; Bile Duct Neoplasms; Cadaver; Humans; Kidney Transplantation; Male | 1993 |
One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of age.
Topics: Age Factors; Aged; Azathioprine; Cadaver; Creatinine; Cyclosporine; Female; Humans; Kidney Transplan | 1993 |
Causes of late graft failure in cadaveric renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Female; Follow-Up Studies; Huma | 1993 |
De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.
Topics: Australia; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Kidney Transplantation; Morbidity; N | 1993 |
Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
Topics: Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Hum | 1993 |
Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Cadaver; Calcium Channel Blockers; Cyclosporine; Drug T | 1993 |
Kidney transplantation at one center: 1-year results.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Histo | 1996 |
Accelerated acute rejection in renal allograft.
Topics: Acute Disease; Age Factors; Azathioprine; Cadaver; Cyclosporine; Female; Graft Rejection; Graft Surv | 1996 |
Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Thera | 1996 |
Treatment of peripheral leukopenia after cadaveric kidney transplantation.
Topics: Adenine; Adult; Azathioprine; Blood Transfusion; Cadaver; Drug Therapy, Combination; Female; Glycery | 1996 |
A single-center multiple regression analysis of covariates associated with long-term cadaveric renal allograft survival: further improvement of long-term results with CsA.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Female; Graft Survival; Humans; Immunosuppressive Agents | 1995 |
[Economic contribution of mofetil mycofenolate as preventive immunosuppressive treatment after renal transplantation from cadaver].
Topics: Adult; Ambulatory Care; Azathioprine; Cadaver; Costs and Cost Analysis; Graft Rejection; Hospitaliza | 1996 |
Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
Topics: Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Rejection; HLA-DR Antigens; Hu | 1996 |
Chagas disease and transplantation.
Topics: Adult; Antilymphocyte Serum; Argentina; Azathioprine; Cadaver; Chagas Disease; Child; Cyclosporine; | 1996 |
Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Topics: Actuarial Analysis; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Cohort Studies; Cre | 1997 |
Reversal of accelerated renal allograft rejection with FK 506.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies; Antilymphocyte Serum; Azathioprine; Biopsy; Cadave | 1997 |
Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Analysis of Variance; Antilymphocyte | 1996 |
Results of renal transplantation five to twenty-six years after surgery, using azathioprine and low-dose prednisolone as sole immunosuppression.
Topics: Azathioprine; Cadaver; Drug Therapy, Combination; Family; Graft Survival; Hospitals, University; Hos | 1996 |
The impact of pre-transplant obesity on renal transplant outcomes.
Topics: Adult; Azathioprine; Body Mass Index; Cadaver; Cyclosporine; Diabetes Mellitus; Female; Glucocortico | 1997 |
The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
Topics: Administration, Oral; Age Factors; Aged; Azathioprine; Cadaver; Cyclosporine; Female; Glucocorticoid | 1997 |
Steroid withdrawal in kidney transplant recipients: is it a safe option?
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Cadaver; Creatinine; Cyclosporine; Drug Monitoring; F | 1997 |
Effect of early cyclosporine levels on kidney allograft rejection.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cadaver; Cyclosporine; Graft Rejection; Graft Surviva | 1997 |
Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschool; Cyclo | 1997 |
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
Topics: Azathioprine; Black or African American; Black People; Cadaver; Cyclosporine; Drug Therapy, Combinat | 1997 |
Characteristics of long-term renal transplant survivors.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Coronary Disease; Female; Follow- | 1998 |
Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immun | 1998 |
Results of various immunosuppressive regimens at our transplantation center.
Topics: Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Family; Female; Humans; Immunosuppre | 1998 |
Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Follow-Up Studies; Graft Surviva | 1998 |
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Costs and Cost Analysis; Graft Rejection; Hospitals, University; Humans; Immu | 1998 |
Male recipients of kidneys from female donors are at increased risk of graft loss from both rejection and technical failure.
Topics: Adult; Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclosporine; Female; F | 1999 |
Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; | 1999 |
Effect of increased arterial resistance index on long-term outcome of well-functioning kidney grafts.
Topics: Adult; Azathioprine; Blood Pressure; Cadaver; Cyclosporine; Female; Graft Survival; Humans; Immunosu | 2000 |
Quality of life after cadaveric renal transplantation from a non-heart-beating donor.
Topics: Activities of Daily Living; Azathioprine; Cadaver; Cyclosporine; Graft Survival; Heart Arrest; Human | 2000 |
Increasing incidence of steroid resistant rejection in kidney transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Drug Resistance; Drug Therapy, Combinatio | 2000 |
Immune activation gene expression in CD28 costimulated lymphocytes and its application as a diagnostic tool in kidney transplantation.
Topics: Adult; Antigens, CD; Azathioprine; Biomarkers; Cadaver; CD28 Antigens; CD40 Ligand; Cyclosporine; Cy | 2000 |
Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclosporine; Cytomegalovirus Infect | 2000 |
[Acute pancreatitis after kidney transplantation].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; | 2001 |
Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graf | 2001 |
[Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Cytomegalovirus Infections; Dose-Respo | 2001 |
Thrombocytopenic episodes in patients with well-functioning renal allografts. Inverse relationship between platelet count and platelet size pointing to intermittent platelet destruction.
Topics: Autoantibodies; Azathioprine; Blood Cell Count; Blood Platelets; Cadaver; Cell Survival; Creatinine; | 1979 |
Donor pretreatment as an adjunct to cadaver renal allotransplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cyclophosphamide; Female; Graft Rejection; Histocompatibil | 1975 |
Donor pretreatment in cadaver renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cobalt Radioisotopes; Cyclophosphamide; Female; Graft Surv | 1977 |
Aspergillus fumigatus epidural abscess in a renal transplant recipient.
Topics: Abscess; Aspergillosis; Aspergillus fumigatus; Azathioprine; Cadaver; Graft Rejection; Humans; Kidne | 1978 |
Chronic granulocytic leukemia in a renal transplant recipient.
Topics: Azathioprine; Cadaver; Humans; Kidney Transplantation; Leukemia, Myeloid; Male; Middle Aged; Oncogen | 1978 |
Chronic granulocytic leukemia following successful renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Chromosomes, Human, 21-22 and Y; Chromosomes, Human, 6-12 and X; Human | 1978 |
Failure of blood transfusions to improve cadaveric renal allograft survival.
Topics: Azathioprine; Blood Transfusion; Cadaver; Cyclophosphamide; Female; Graft Survival; Humans; Kidney T | 1978 |
Trends in immunosuppression for kidney transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Drug Therapy, Combination; Graft Survival; Humans; Immu | 1978 |
Cadaveric renal graft acceptance without azathioprine.
Topics: Azathioprine; Cadaver; Creatinine; Female; Graft Rejection; Graft Survival; Hematologic Diseases; He | 1979 |
Treatment of acute allograft rejection with high doses of corticosteroids.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Child; Child, Pres | 1976 |
Periactin (cyproheptadine hydrochloride) as a supplement to the immunosuppressive treatment in human cadaver kidney transplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cyproheptadine; Drug Therapy, Combination; Graft Rejection | 1976 |
Factors related to success or failure of second renal transplants.
Topics: Adolescent; Adult; Antibodies; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschool; | 1976 |
Influence of rejection on graft survival after renal transplantation.
Topics: Azathioprine; Cadaver; Dose-Response Relationship, Drug; Graft Rejection; HLA Antigens; Humans; Kidn | 1976 |
[Studies on the correlation behavior of IgG and serum albumin after kidney transplantation under high steroid medication].
Topics: Antibody Formation; Azathioprine; Cadaver; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidne | 1976 |
The effect of recurrent early homograft rejection on subsequent patient and renal graft survival.
Topics: Acute Disease; Azathioprine; Cadaver; Drug Administration Schedule; Graft Rejection; Humans; Kidney | 1976 |
Cost-benefit ratio of pretransplant bilateral nephrectomy.
Topics: Administration, Oral; Azathioprine; Cadaver; Cost-Benefit Analysis; Graft Rejection; Humans; Injecti | 1976 |
Norwegian scabies: occurrence in a patient undergoing immunosuppression.
Topics: Adult; Azathioprine; Cadaver; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplanta | 1976 |
Renal transplantation in pediatric patients.
Topics: Acute Kidney Injury; Adolescent; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschoo | 1975 |
Extensive intraglomerular fibrin deposition after renal transplantation: recovery without anticoagulation.
Topics: Acute Kidney Injury; Azathioprine; Biopsy, Needle; Cadaver; Cyclophosphamide; Fibrin; Graft Rejectio | 1975 |
Renal transplantation in the older age group.
Topics: Acute Kidney Injury; Age Factors; Aged; Azathioprine; Cadaver; Coronary Disease; Diabetes Complicati | 1975 |
A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Cytomegalovirus Infect | 1992 |
Renal transplantation in Singapore.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Failur | 1992 |
Collaborative Transplant Study--10-year report.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft | 1992 |
Enhanced renal graft survival in HLA-A mismatched transplants.
Topics: Adult; Azathioprine; Blood Transfusion; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Fo | 1992 |
Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Cause of Death; Cyclosporine; Dose-Response Relationship, Drug; Drug A | 1992 |
Postoperative endogenous serum cortisol level as indicator of the immunosuppressive efficacy of prednisolone in kidney allograft recipients.
Topics: Adult; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Administration Schedule; Drug Therapy, | 1992 |
Protective effect of cyclosporine in human renal posttransplant cryptococcosis.
Topics: Azathioprine; Cadaver; Cryptococcosis; Cyclosporine; Drug Therapy, Combination; Humans; Kidney Trans | 1992 |
Cancer after transplantation in Catalonia.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transp | 1992 |
The impact of triple drug immunosuppression on clinical results of cadaveric kidney transplantation: a comparison of conventional immunosuppression.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppres | 1992 |
Factors affecting renal allograft function in long-term recipients.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Diabetic Nephropathies; Female; Graft Survival; Humans; Hy | 1992 |
Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Black People; Cadaver; Cyclosporine; Drug Therapy, Combin | 1992 |
Transient pure red cell aplasia caused by antilymphoblast globulin after cadaveric renal transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Blood Cell Count; Cadaver; Erythropoies | 1991 |
Highly sensitized patients with delayed graft function: a management protocol.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cyclosporins; Female; Graft Rejection; Graft Survival; Hum | 1991 |
Long-term results with cyclosporine immune suppression in pediatric cadaver renal transplantation.
Topics: Adolescent; Age Factors; Azathioprine; Cadaver; Child; Cyclosporins; Growth; Humans; Hypercholestero | 1991 |
Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA.
Topics: Age Factors; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Humans; Immunosuppressi | 1991 |
Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients.
Topics: Adult; Azathioprine; Cadaver; Cyclosporins; Follow-Up Studies; Graft Rejection; Graft Survival; Hist | 1991 |
[4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Drug Therap | 1990 |
Elective conversion from cyclosporine to azathioprine in sensitized patients following cadaveric renal transplantation.
Topics: Actuarial Analysis; Adult; Antibodies; Azathioprine; Cadaver; Cyclosporins; Graft Survival; HLA Anti | 1990 |
Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Graft Rejection; Gr | 1990 |
Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cadaver; Chromatography, High Pressure L | 1990 |
Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Cadaver; Chromatography, High Pressure | 1990 |
Triple therapy immunosuppression in cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Female; Graft Rejection; Graf | 1990 |
[Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
Topics: Azathioprine; Cadaver; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1990 |
An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
Topics: Adult; Azathioprine; Cadaver; Cyclosporins; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1990 |
Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporins; Graft Survival; Humans; Immunosuppression Therapy; | 1990 |
High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
Topics: ABO Blood-Group System; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Follow-Up Studies | 1990 |
Renal transplantation between living-related sibling pairs matched for zero-HLA haplotypes.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Graft Survival; Haplotypes; Histocompatib | 1989 |
Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Graft Rejec | 1989 |
Long-term results of O-antigen match cadaver transplants--a single-institution study.
Topics: Autoantigens; Azathioprine; Cadaver; Cyclosporins; Follow-Up Studies; Graft Survival; Histocompatibi | 1989 |
Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Cyclosporins; Drug Therapy, Combination; Female; Fo | 1989 |
Triple-drug regimen (TDR) of AZA + CsA + P: new definition of factors influencing kidney graft survival at a single center.
Topics: Adult; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Female; Follow-Up Studies; Gr | 1989 |
Cadaver renal transplantation in children using low dose triple immunosuppression.
Topics: Adolescent; Azathioprine; Blood Transfusion; Cadaver; Child; Cyclosporins; Drug Administration Sched | 1989 |
Prednisone used as treatment for rejection correlates with poor outcome.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Drug Administration Schedule; Follow-Up Studies; Graft | 1989 |
Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.
Topics: Azathioprine; Cadaver; Capsid; Cyclosporins; Follow-Up Studies; Herpesvirus 4, Human; Humans; Immuno | 1987 |
Ten-year results of renal transplantation with azathioprine and prednisolone as only immunosuppression.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cause of Death; Graft Survival; Humans; Immunosuppression | 1988 |
Early arteriolopathy following "high-dose" cyclosporine in kidney transplantation.
Topics: Age Factors; Arterioles; Azathioprine; Biopsy; Cadaver; Cyclosporins; Graft Rejection; Humans; Kidne | 1988 |
Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Diabetes Complications; Drug Thera | 1987 |
Comparable success rates are now possible for higher- and lower-risk cadaveric kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Child; Child, Preschool; Cyclosporins; Female; Graft | 1987 |
Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at Houston.
Topics: Azathioprine; Blood Transfusion; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Enhancement | 1988 |
Long-term results of cadaveric kidney transplantation in children.
Topics: Azathioprine; Cadaver; Child; Creatinine; Follow-Up Studies; Graft Rejection; Graft Survival; Humans | 1987 |
Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
Topics: Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Cadaver; Cyclosporins; Graft Survival; Histocompa | 1987 |
Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclosporins; Drug Administration Sc | 1987 |
Quadruple therapy for cadaver renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Blood Grouping and Crossmatching; Cadaver; Cyclosporins; Drug Th | 1987 |
Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Humans; Immuno | 1987 |
Prognostic significance of hepatitis B surface antigenemia in cadaveric renal transplant patients.
Topics: Azathioprine; Cadaver; Cyclosporins; Graft Survival; Hepatitis B Surface Antigens; Humans; Kidney Tr | 1987 |
Effect of DR and DR6 matching on cadaver kidney transplant survival.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Follow-Up Studies; Graft Survival; Histoc | 1987 |
Late cyclosporine conversion carries risk of irreversible rejection.
Topics: Azathioprine; Cadaver; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1988 |
The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
Topics: ABO Blood-Group System; Azathioprine; Blood Transfusion; Cadaver; Cyclosporins; Graft Rejection; HLA | 1988 |
Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
Topics: Azathioprine; Blood Transfusion; Cadaver; Creatinine; Cyclosporins; Graft Survival; HLA Antigens; HL | 1988 |
Conventional immunosuppressive therapy in modern renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Female; Graft Survival; Humans; I | 1988 |
The current role of pre-transplant blood transfusions and tissue typing in cadaveric renal transplantation.
Topics: Azathioprine; Blood Transfusion; Cadaver; Cyclosporins; Graft Survival; Histocompatibility Testing; | 1987 |
Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Survival | 1987 |
Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
Topics: Azathioprine; Bacterial Infections; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Rejectio | 1987 |
Low-dose triple immunosuppression in pediatric cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Child; Cyclosporins; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1987 |
Early experience with cyclosporine in renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Cyclosporins; Female; Humans; Inf | 1986 |
Cyclosporine use in early graft dysfunction.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporins; Graft Survival; Humans; Kidney; Kidney Transplantat | 1986 |
Low dose cyclosporine strategy for cadaver kidney transplantation.
Topics: Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Rejection; Humans; Kidney Tran | 1986 |
The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; HLA Antigens; | 1986 |
Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Blood Transfusion; Cadaver; Child; Chil | 1986 |
Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Rejectio | 1986 |
The role of antilymphocyte globulin in cadaver renal transplantation.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Evaluation; | 1986 |
[Experience of kidney transplantation in 350 patients].
Topics: Adult; Azathioprine; Cadaver; Cyclosporins; Female; Graft Survival; Humans; Kidney Diseases; Kidney | 1986 |
Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Cyclosporins; Graft Rejection; Graft Survival; Humans; Kidney Transplantation | 1987 |
Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Cyclosporins; Graft Survival; HLA-D Antigens; HLA-DR Antigens; HLA-DR6 | 1987 |
Triple and quadruple therapy after renal transplantation in patients from developing countries.
Topics: Azathioprine; Cadaver; Cyclosporins; Developing Countries; Drug Therapy, Combination; Glucocorticoid | 1987 |
Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Rejectio | 1987 |
Adverse effects of low-dose azathioprine on Australian primary graft survival (1978-1984).
Topics: Australia; Azathioprine; Cadaver; Creatinine; Dose-Response Relationship, Drug; Graft Survival; Hist | 1987 |
Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporins; Drug Therapy, Combination; Glomerular Filtration Ra | 1987 |
Limiting factors in successful preservation of cadaveric kidneys with ischemia time exceeding 50 hours.
Topics: Azathioprine; Cadaver; Cold Temperature; Cyclosporins; Humans; Immunosuppression Therapy; Ischemia; | 1987 |
The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
Topics: Adult; Azathioprine; Bone Marrow Diseases; Cadaver; Cyclosporins; Dose-Response Relationship, Drug; | 1987 |
Ciclosporin and ischemia time in renal transplant.
Topics: Azathioprine; Cadaver; Cold Temperature; Cyclosporins; Humans; Ischemia; Kidney; Kidney Transplantat | 1986 |
Low-dose ciclosporin in cadaveric renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Drug Therap | 1986 |
Renography and biopsy-verified acute rejection in renal allotransplanted patients receiving cyclosporin A.
Topics: Azathioprine; Biopsy; Cadaver; Cyclosporins; Graft Rejection; Humans; Kidney; Kidney Transplantation | 1987 |
Neoplasia in immunosuppressed renal transplant patients: a 20-year experience.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschool; Cyclo | 1985 |
Renal transplantation in the older recipient.
Topics: Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver; Cardiomyopathies; Coronary Disease; Diabet | 1985 |
[Late prognosis of kidney transplantation in children].
Topics: Adolescent; Azathioprine; Cadaver; Child; Child, Preschool; Follow-Up Studies; Graft Rejection; Graf | 1985 |
Cyclosporine in renal transplantation: a single institutional experience.
Topics: Azathioprine; Blood Pressure; Cadaver; Cost-Benefit Analysis; Cyclosporins; Drug Evaluation; Follow- | 1985 |
Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Azathioprine; Cadaver; Cyclosporins; Female; Humans; Immunosup | 1985 |
[Clinical picture of kidney transplantation. Surgical report].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Dactinomycin; Gastrointestinal Hemorrhage; Graft vs Hos | 1968 |
De-novo brain tumours in renal-transplant recipients.
Topics: Adolescent; Adult; Azathioprine; Brain; Brain Neoplasms; Cadaver; Follow-Up Studies; Humans; Immunos | 1971 |
Human renal transplantation with kidney grafts from the newborn.
Topics: Adolescent; Anencephaly; Azathioprine; Cadaver; Child; Female; gamma-Globulins; Graft Rejection; Hum | 1971 |
[Renal homotransplantation in men. Results achieved in 37 patients 26 of whom had received antilymphocyte globulins].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Creatine; gamma-Globulins; Histocompatibility; Humans; | 1969 |
[The role of histocompatibility and antilymphocyte globulins in the early development of human renal homotransplantation].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Dactinomycin; gamma-Globulins; Histocompatibility; Huma | 1969 |
Cyclophosphamide and human organ transplantation.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Consa | 1971 |
Renal transplantation in two cases of amyloidosis.
Topics: Abscess; Adult; Age Factors; Amyloidosis; Antilymphocyte Serum; Autopsy; Azathioprine; Biopsy; Cadav | 1971 |
Survival of a homologous parathyroid implant in an immunosuppressed patient.
Topics: Administration, Oral; Azathioprine; Cadaver; Calcium; Creatinine; Cyclophosphamide; Gluconates; Huma | 1973 |
Hypophosphataemic osteomalacia after cadaveric renal transplantation.
Topics: Acidosis; Alkaline Phosphatase; Azathioprine; Bicarbonates; Cadaver; Calcium; Chlorides; Creatinine; | 1974 |
Assessment of human renal transplantation.
Topics: Antibodies; Azathioprine; Blood Transfusion; Cadaver; Cytotoxicity Tests, Immunologic; DNA; Evaluati | 1974 |
Colonic complications after renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Colectomy; Colitis; Colon; Diarrhea; Female; Gastrointesti | 1973 |
[Cadaver kidney homologous transplant. Clinical results in 64 patients].
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Bacterial Infections; Cadaver; Graft vs Host | 1971 |
Cadaveric transplants.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Dactinomycin; Humans; Kidney Transplantation; Middl | 1966 |
Further observations on renal transplants in man from cadaveric donors.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Blood Pressure Determination; Cadaver; Calcium; Dactinom | 1966 |
Some urological aspects of 93 consecutive renal homotransplants in modified recipients.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Dactinomycin; Female; Humans; Immunosuppressive Age | 1967 |
Significance of erythrocytosis and increased erythropoietin secretion after renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Dactinomycin; Erythropoietin; Female; Humans; Immune Tolerance; Kidney | 1967 |
Three years' clinical experience with cadaver kidney transplantation.
Topics: Anuria; Azathioprine; Cadaver; Dactinomycin; Humans; Immunosuppressive Agents; Kidney Function Tests | 1967 |
Four years' clinical experience with 138 kidney transplants.
Topics: Antibodies, Anti-Idiotypic; Azathioprine; Cadaver; Dactinomycin; Humans; Kidney Transplantation; Pre | 1967 |
Extended survival in 3 cases of orthotopic homotransplantation of the human liver.
Topics: Acidosis; Azathioprine; Biliary Tract; Cadaver; Child, Preschool; Female; gamma-Globulins; Humans; I | 1968 |
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation.
Topics: Adolescent; Adult; Azathioprine; Blood Cell Count; Cadaver; Child; Creatinine; Follow-Up Studies; ga | 1968 |
Tissue immunity and organ transplantation.
Topics: Adult; Azathioprine; Biopsy; Blood Pressure; Blood Urea Nitrogen; Cadaver; Creatinine; Dactinomycin; | 1968 |
Heparin in delayed transplant function.
Topics: Adult; Azathioprine; Blood Platelets; Cadaver; Capillaries; Dactinomycin; Female; Heparin; Humans; K | 1968 |
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula.
Topics: Azaserine; Azathioprine; Cadaver; Carcinoma, Squamous Cell; Dactinomycin; Female; Fistula; Humans; H | 1968 |
Perspectives in organ transplantation.
Topics: Adult; Alpha-Globulins; Antigens; Antilymphocyte Serum; Azathioprine; Beta-Globulins; Cadaver; Elect | 1969 |
[Indications and results of renal transplantation].
Topics: Acute Kidney Injury; Adult; Antibodies; Azathioprine; Blood Group Antigens; Cadaver; Child; Culture | 1970 |
Antilymphocyte-serum preparations in treatment of renal-allograft rejection.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Female; gamma-Globulins; Histocompatibility; Hum | 1970 |
Leukocyte (3H) thymidine uptake in short-term whole-blood cultures of human and canine renal allograft recipients.
Topics: Animals; Azathioprine; Cadaver; Dogs; Graft Rejection; Hodgkin Disease; Humans; Immunity, Cellular; | 1973 |
The period and nature of hazard in clinical renal transplantation. II. The hazard to transplant kidney function.
Topics: Adolescent; Age Factors; Azathioprine; Blood Urea Nitrogen; Cadaver; Child; Creatinine; Female; Hist | 1969 |
A case of homologous liver transplantation.
Topics: Adult; Aldosterone; Ampicillin; Azathioprine; Cadaver; Carcinoma, Hepatocellular; Heparin; Humans; L | 1969 |
Hepatic dysfunction after renal transplantation in children.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Azathiop | 1972 |
Chronic immunosuppression and occult lymphoma: a case report.
Topics: Adult; Azathioprine; Bone Neoplasms; Cadaver; Carcinoma, Squamous Cell; Cytomegalovirus Infections; | 1972 |
Prevention of death after renal transplantation. I. Recognizable patterns leading to death in long-term survivors.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Death; Female; Graft vs Host Reaction; Humans; Infe | 1970 |
Two years' experience with cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Female; Graft vs Host Reaction; Histocompatibility Testing; Humans; Hy | 1971 |
Ileocolonic problems after cadaveric renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Colon; Colon, Sigmoid; Female; Humans; Ileum; Intestina | 1972 |
Renal homotransplantation in infants and children with the hemolytic-uremic syndrome.
Topics: Anemia, Hemolytic; Antilymphocyte Serum; Azathioprine; Blood Urea Nitrogen; Cadaver; Child; Creatini | 1972 |
Functional recovery from acute rejection as a guide to ultimate renal graft survival.
Topics: Azathioprine; Blood Urea Nitrogen; Cadaver; Creatinine; Graft Rejection; Humans; Immunosuppression T | 1972 |
Further assessment of rosette inhibition test in clinical organ transplantation.
Topics: Animals; Antibody Formation; Antigen-Antibody Reactions; Antilymphocyte Serum; Azathioprine; Cadaver | 1972 |
The immunosuppressive effect of large doses of intravenous prednisolone in experimental heterotopic rat heart and human renal transplantation.
Topics: Animals; Azathioprine; Cadaver; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Ag | 1973 |
Review of human renal transplantation at the Toronto General Hospital.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Female; Follow-Up Studies; Graft Rejection; Histocompatibi | 1973 |
[Follow-ups after kidney transplantations].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Follow-Up Studies; Germany, West; Graft Rejection; Huma | 1973 |
Cyclophosphamide for clinical renal and hepatic transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclophosphamide; Humans; Immunosuppression Therapy; Ki | 1973 |
Reduction of immunogenicity of human cadaver renal allografts by donor pretreatment.
Topics: Antigens; Azathioprine; Blood Pressure; Cadaver; Creatinine; Cyclophosphamide; Cytotoxicity Tests, I | 1973 |
Renal transplantation in young children.
Topics: Age Factors; Azathioprine; Bone Diseases; Cadaver; Cataract; Child; Child, Preschool; Epiphyses, Sli | 1973 |
Spontaneous rupture of renal allotransplants.
Topics: Adult; Azathioprine; Biopsy; Cadaver; Female; Graft Rejection; Histocompatibility Testing; Humans; K | 1973 |
Treatment of renal failure from diabetic nephropathy with cadaveric homograft.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Diabetes Mellitus, Type 1; Diabetic | 1973 |
Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.
Topics: Antibodies; Antilymphocyte Serum; Aspartate Aminotransferases; Azathioprine; Cadaver; Carrier State; | 1973 |
Improvement in cadaveric renal transplant survival.
Topics: Age Factors; Antilymphocyte Serum; Azathioprine; Biopsy, Needle; Brain Death; Cadaver; Cyclophospham | 1973 |
Polycystic renal disease treated by renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Diagnosis, Differential; Evaluation Studies as Topic; Female; Follow-U | 1973 |
The appearance of reticulum cell sarcoma at the site of antilymphocyte globulin injection.
Topics: Amphotericin B; Antibodies; Antilymphocyte Serum; Azathioprine; Buttocks; Cadaver; Cryptococcosis; C | 1973 |
Pregnancy in a patient after cadaveric renal transplantation.
Topics: Adult; Agglutinins; Azathioprine; Biopsy; Blood Pressure; Cadaver; Estrogens; Female; Graft Rejectio | 1973 |
Factors responsible for urinary fistula in the renal transplant recipient.
Topics: Azathioprine; Cadaver; Graft Rejection; Humans; Kidney; Kidney Transplantation; Postoperative Compli | 1973 |
Renal dialysis and kidney transplantation program for the state of Maine.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Financing, Government; Hemodialysis, Home; Humans; Kidn | 1973 |
Graft and patient survival after primary cadaver kidney transplantation with special regard to compatibility in the HL-A system.
Topics: Adult; Azathioprine; Biopsy; Cadaver; Female; Follow-Up Studies; Graft Rejection; Histocompatibility | 1973 |
[Adverse effects of immunosuppression following kidney allotransplantation and data on the mechanism of infectious complications].
Topics: Azathioprine; Bacterial Infections; Cadaver; Humans; Immunosuppressive Agents; Kidney Transplantatio | 1973 |
Successful renal transplantation after forty-five hours of extracorporeal perfusion.
Topics: Acute Kidney Injury; Azathioprine; Biopsy; Cadaver; Cold Temperature; Drug Hypersensitivity; Graft R | 1973 |
Role of splenectomy in renal transplantation.
Topics: Analysis of Variance; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Graft Rejection; Huma | 1973 |
Urinary tract infection after renal transplantation.
Topics: Adolescent; Adult; Ampicillin; Azathioprine; Bacteriuria; Cadaver; Female; Glomerulonephritis; Human | 1973 |
Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Cyclophosphamide; Female; Follow-Up Studies; Graft | 1973 |
The influence of histocompatibility on graft and patient survival in primary cadaver kidney transplantation.
Topics: Age Factors; Azathioprine; Cadaver; Cytotoxicity Tests, Immunologic; Graft Rejection; Histocompatibi | 1972 |
Evaluation of corticosteroid therapy for acute renal allograft rejection.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Creatinine; Female; Graft Rejection; Humans; Immuno | 1974 |
Fanconi syndrome following homotransplantation.
Topics: Adult; Azathioprine; Cadaver; Carbon Dioxide; Creatinine; Fanconi Syndrome; Glycosuria; Humans; Kidn | 1974 |
Kaposi sarcoma in kidney transplant recipients.
Topics: Adult; Antilymphocyte Serum; Autopsy; Azathioprine; Brain Neoplasms; Cadaver; Female; Graft Rejectio | 1974 |
Premalignant and malignant skin tumours in immunosuppressed patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyc | 1974 |
Renal cadaver transplantation followed by successful pregnancies.
Topics: Adult; Azathioprine; Birth Weight; Cadaver; Cesarean Section; Extraembryonic Membranes; Female; Glom | 1974 |
A controlled trial of anticoagulants in cadaveric renal transplantation.
Topics: Azathioprine; Blood Coagulation; Cadaver; Creatinine; Drug Evaluation; Fibrin; Graft Rejection; Hemo | 1974 |
Surgical treatment of Staphylococcus aureus endarteritis in a hemodialysis arteriovenous fistula.
Topics: Adrenal Cortex Hormones; Adult; Arteriovenous Shunt, Surgical; Azathioprine; Cadaver; Cephalexin; Cl | 1974 |
The effect of extracorporeal irradiation of the blood in necrokidney transplantation. Three years' follow-up study.
Topics: Adult; Antibodies; Azathioprine; Cadaver; Chronic Disease; Creatinine; Dose-Response Relationship, R | 1974 |
Partial lipodystrophy and chronic hypocomplementemic glomerulonephritis.
Topics: Adult; Azathioprine; Cadaver; Complement System Proteins; Creatinine; Dexamethasone; Female; Follow- | 1974 |
Splenectomy in renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Foreign-Body Reaction; Graft Rejection; Humans; Hyp | 1974 |
The kidney cell crossmatch in retransplantation.
Topics: Adult; Autoantibodies; Azathioprine; Cadaver; Creatinine; Cytotoxicity Tests, Immunologic; Female; G | 1974 |
Renal transplantation in patients with carcinoma.
Topics: Adult; Angiography; Azathioprine; Cadaver; Female; Graft Rejection; Hematuria; Humans; Immunosuppres | 1974 |
Observations on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation.
Topics: Anemia, Hypochromic; Azathioprine; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Bone Marrow Exa | 1974 |
Kidney transplant nephrotic syndrome.
Topics: Adolescent; Adult; Animals; Azathioprine; Cadaver; Child; Female; Glomerulonephritis; Graft Rejectio | 1974 |
Factors in infectious complications following cadaver renal transplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Bacterial Infections; Cadaver; Horses; Humans; Immunosu | 1973 |
Transplantation of canine cadaver hearts after short-term preservation.
Topics: Animals; Azathioprine; Cadaver; Dogs; Electrocardiography; Heart Transplantation; Humans; Hypothermi | 1967 |
Kindey transplantation: experiences at the University of Minnesota Hospitals.
Topics: Adolescent; Adult; Antigens; Azathioprine; Cadaver; Child; Female; Humans; Ileostomy; Immune Toleran | 1967 |
[Acute pancreatitis after renal transplantation].
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Female; Glomerulonephritis; Humans; Kidney Transplantat | 1967 |
Four years' clinical experience with 138 kidney transplants.
Topics: Azathioprine; Cadaver; Follow-Up Studies; Humans; Kidney Transplantation; Nephrectomy; Postoperative | 1968 |
[First experience with the transplantation of cadaveric kidneys in man].
Topics: Azathioprine; Cadaver; Chronic Disease; Cortisone; Gastrointestinal Hemorrhage; Glomerulonephritis; | 1967 |
[Follow-up studies of Zurich clinical cases].
Topics: Adult; Azathioprine; Cadaver; Chronic Disease; Follow-Up Studies; Glomerulonephritis; Hematologic Di | 1967 |
Orthotopic homotransplantation of the human liver.
Topics: Adolescent; Adult; Azathioprine; Bile Ducts; Cadaver; Child; Child, Preschool; Hepatic Artery; Human | 1968 |
Kidney transplants: 92 cases. Results, lessons learned, future prospects.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Female; Follow-Up Studies; Histocompatibility Testi | 1968 |
Cardiac and other organ transplantation. In the setting of transplant science as a national effort.
Topics: Antilymphocyte Serum; Azathioprine; Bone Marrow Transplantation; Bone Transplantation; Cadaver; Cart | 1968 |
The effect of splenectomy on the survival of first and second renal homotransplants in man.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Female; Humans; Kidney; Kidney Transplantation; Mal | 1968 |
Renal transplantation from cadaver donors.
Topics: Adult; Azathioprine; Cadaver; Histocompatibility Testing; Humans; Kidney Transplantation; Middle Age | 1968 |
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days.
Topics: Azathioprine; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cadaver; Computers; Creatinine; Data | 1969 |
Use of antilymphocyte globulin after cadaveric renal transplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Fever; Horses; Humans; Hypotension | 1969 |
Renal homotransplantation in children.
Topics: Adaptation, Psychological; Adolescent; Anemia; Azathioprine; Cadaver; Child; Child, Preschool; Cyclo | 1970 |
A regional project in hemodialysis and transplantation.
Topics: Anti-Glomerular Basement Membrane Disease; Antilymphocyte Serum; Azathioprine; Cadaver; Calcium Meta | 1970 |
Renal transplantation in a community hospital.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Female; Hospital Departments; Humans; Kidney Transplantati | 1970 |
Kidney transplantation in children.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Height; Cadaver; Child; Child, Preschool; Cushi | 1970 |
[Complications associated with immunodepressive therapy in patients after transplantation of cadaveric kidneys in the early postoperative period].
Topics: Adolescent; Adult; Azathioprine; Cadaver; Female; Humans; Immunosuppressive Agents; Kidney Transplan | 1970 |
Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
Topics: Adult; Animals; Antilymphocyte Serum; Azathioprine; Biopsy; Cadaver; Creatinine; Female; Fluorescent | 1971 |
Cadaveric kidney transplantation in a patient with donor-specific antileukocyte cytotoxic antibodies. Report of a case.
Topics: Antibodies; Antilymphocyte Serum; Autopsy; Azathioprine; Cadaver; Drainage; Female; Graft Rejection; | 1971 |
Results of kidney transplantation in Poland.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Female; Histocompatibility Testing; Humans; Immunos | 1971 |
Present status of renal transplantation.
Topics: Adrenal Cortex Hormones; Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Globulins; Histocompa | 1971 |
Leucopenia associated with trimethoprim-sulphamethoxazole after renal transplantation.
Topics: Azathioprine; Cadaver; Creatinine; Folic Acid Antagonists; Humans; Kidney Transplantation; Leukopeni | 1971 |
Chromosome aberrations in the child of a kidney transplant recipient.
Topics: Abnormalities, Drug-Induced; Adult; Azathioprine; Cadaver; Chromosome Aberrations; Female; Fetus; Hu | 1971 |
Renal transplantation in infants and small children.
Topics: Acute Kidney Injury; Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Prescho | 1971 |
[Clinical use and results of immunodepressive treatment with anti-lymphocyte immunoglobulins in human renal allotransplantation].
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Chronic Disease; Drug Tolerance; Female; Glomeru | 1971 |
[Kidney transplantation].
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Glomerulonephritis; Histocompatibility Testing; Huma | 1971 |
Analyses of histocompatibility in cadaver renal transplantation.
Topics: ABO Blood-Group System; Antibody Specificity; Australia; Azathioprine; Cadaver; Creatinine; Cytotoxi | 1971 |
Selection of donors for kidney transplantation.
Topics: Alleles; Azathioprine; Cadaver; Creatinine; Cytotoxicity Tests, Immunologic; Histocompatibility Test | 1971 |
Clinical experience with cardiac transplantation: retrospective considerations.
Topics: Adult; Azathioprine; Bacterial Infections; Cadaver; Graft Rejection; Heart; Heart Transplantation; H | 1971 |
Radiation for immunosuppression in human organ transplantation. II. Clinical experience.
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Blood; Cadaver; Child; Dogs; Extraco | 1971 |
Professor Hamburger on renal transplantation.
Topics: Azathioprine; Cadaver | 1971 |
Human cadaveric renal transplantation. Report of twenty cases.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Female; Humans; Hydrocortisone; Kidney Diseases; Kidney Tr | 1965 |
Clinical experience with the use of 79 kidneys from cadavers for transplantation.
Topics: Azathioprine; Cadaver; Humans; Kidney Failure, Chronic; Kidney Transplantation; Postoperative Compli | 1966 |
The use of ninety-four cadaveric kidneys for transplantation--clinical experience.
Topics: Azathioprine; Cadaver; Humans; Kidney Failure, Chronic; Kidney Transplantation; Nephrectomy; Postope | 1966 |